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ABSTRACT 
Efficient and facile transfection of nucleic acids is a good tool for biological 
research and diagnostic applications. The crescent develop of gene transfer 
techniques for genomic studies, in particular has involved an increase of the 
investigations on gene transfer mediated by the substrate. This strategy is suitable 
for the manufacturing of screening platforms, such as microarrays, to in vivo and in 
vitro assays. Substrate-mediated transfection methods were described for delivering 
DNA in a slow release manner, but there is a critical need to modulate gene transfer 
process. In other words, a good gene delivery platform have to stably retain the 
gene vectors for prolonged periods and at same time mediate a efficient gene 
transfer when cells come in contact with it. To this address, we have investigated 
on different approaches of substrate-meditated delivery. In particular, have studied 
three kinds of interaction between gene vectors and substrate with the aim to find a 
compromise between the interaction strength and the effective gene transfer from 
substrate.  
In the first instance, the process through which DNA-vectors were stably tethered 
to a glass substrate result inefficient to mediate the transfection, despite PEI/DNA 
complexes were internalized by the cells seeded on this functionalized substrates. 
We hypothesize that a low surface density of complexes, therefore an ineffective 
immobilization capability affect the subsequent gene transfer. Another factor be 
taken into account is the high co-localization of the internalized complexes with 
lysosomal compartments which suggests the likely involvement of a wrong 
mechanism of internalization by the cells placed on modified substrate. 
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Starting from this results, we have subsequently designed a substrate-mediate 
delivery with PEI/DNA complexes aspecifically adsorbed to glass slides. As 
expected, the successful transfection was probably affected by substrate release of 
the gene particles, as the quantification of the DNA/PEI complexes internalized by 
cells seeded on substrates in time indicates. In this case, in fact, there is not high 
lysosomal co-localization of the complexes inside cells on substrates.  
At least, we have conduct a preliminary study with the aim to test a specific 
adsorption of gene particles to the substrate. To address this purpose we have 
investigated the binding affinity of a linker peptide to fibronectin coated substrate. 
Preliminary results confirm the specificity of selected peptide for the protein, in 
this way it will be possible adsorbed PEI/DNA complexes in specific way to a 
coated substrate, that simultaneously promotes cellular adhesion. This strategy to 
built a substrate-mediate gene delivery platform can be implement with the spatial 
protein patterning such as adhesive/transfective islands on substrate  
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Introduction 
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1.1 Introduction 
Gene expression within a cell population can be directly altered through gene 
delivery approaches, which have tremendous potential for therapeutically uses, 
such as gene therapy and tissue engineering, or in research and diagnostic 
applications, such as functional genomics. However a critical factor limiting the 
development of these applications is the inefficiency of gene transfer. The 
introduction of correctly functioning DNA into cells is a non-trivial matter, and 
cells must be coaxed to internalize, and then use, the DNA in the desired manner 
[1]. Direct injection of mg quantities of ‘naked’ DNA is usually well tolerated but 
still only yields very low levels of transfection. Since degradation of naked DNA 
by serum nucleases limits systemic administration, a number of polymer-based 
synthetic systems, or gene delivery vectors, have been developed in order to entice 
cells to use exogenous DNA and to enhance the stability of the delivered nucleic 
acids. Synthetic gene-delivery platforms have the intent to enhance the efficiency 
of gene transfer to the target cells and typically encompass three length scales - 
nano, micro and macro - depending on what is the desired cell type, anatomical site 
or diagnostic application [2]. Nanoscale delivery relates to vectors, which consist 
of nucleic acids packaged by proteins, lipids, or polymers. This complexation 
between nucleic acids and vectors produces small particles less negatively charged 
relative to the nucleic acid, protects against degradation and facilitates the 
intracellular trafficking. Most research efforts are focus on enhancing the efficacy 
of synthetic vectors to overcome one or more of the barriers to delivery. Microscale 
delivery vectors focus on the potential to deliver genes at a controlled rate for 
systemic uses. Delivery of the nucleic acid, indeed, requires to target a site of 
action, promote internalization by specific cell, escape from the endosome into the 
cytoplasm, transport into the nucleus for transcription, and ultimately protein 
production. Macroscale systems are two-dimensional (2D) or 3D scaffolds 
designed to deliver DNA to a population of cells proximal to the scaffold surface, 
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for tissue engineering and other applications [3, 4]. Biodegradable polymer 
scaffolds act as mechanical supports for initial growth of the cell seeded onto, and 
biomaterials can enhance gene transfer by maintaining consistent levels of the 
vector in the microenvironment of the cell [5]. However, cells in culture are 
generally grown on flat, 2D surfaces and represent an useful tool for cell-biology 
studies. Traditional delivery of vectors known as systemic or bolus delivery, leads 
to the presence of vector in the target cell population for a short time prior to 
clearance, aggregation, or degradation [6]. However DNA transfer to cells in 
culture can also be improved by DNA delivery from the cell growth substrate. 
These systems, termed substrate-mediated delivery, involve immobilization of 
either vectors to a surface that supports cell adhesion and control the rate at which 
plasmid DNA is delivered to the underside of cells grown at a solid or semi-solid 
interface. Substrate immobilization places the vector directly in the cellular 
microenvironment to reduce the amount of DNA required, preventing aggregation 
and distributing the DNA homogeneously among the cell population; it can 
potentially be used to spatially regulate gene transfer [7]. The immobilization of 
DNA to the surface can be through non-specifically adsorption, a receptor–ligand 
interaction, or by encapsulation within a matrix. One of the original reports focused 
on the development of microarrays to analyze the functions of specific gene-
expression products [8]. On the other hand, a new strategy that uses the layer-by-
layer approach to form multilayered polyelectrolyte thin films has been developed 
to incorporate and subsequently release DNA from a surface [9]. Other 
investigators have reported hybrid approaches where plasmid DNA, associated 
with gene vectors, was tethered to a surface to affect DNA delivery to the basal 
side of cells seeded to the surface
 
[10, 11]. However, the success of research 
activity for gene delivery from 2D and 3D surfaces can be evaluated on a case-by-
case basis.  
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1.2 Vectors for gene delivery 
Although plasmid DNA provides transfection in vivo, packaging of nucleic acids 
with cationic lipids or polymers can facilitate uptake and increase expression of 
therapeutic gene or knockdown expression of a specific gene (i.e. RNAi) [12]. 
Complexation can support the uptake by enhancing interactions between positively 
charged DNA complexes and the negatively charged cellular membrane, in 
addition to providing stability against degradation. The success of gene delivery 
strongly depends on the use of vectors that could efficiently deliver the 
therapeutically active genes into the cells. Currently, vectors can be divided into 
two major groups, namely viral vectors derived from natural viruses and non-viral, 
synthetically manufactured vectors. 
 
1.2.1 Viral vectors 
Viral vectors are composed of either DNA or RNA surrounded by a capsid, since it 
is the nature of viruses to deliver their genes into host cells, they present good 
candidates for the development of effective gene delivery [13]. Natural evolution, 
however, optimized them for infecting and replicating their genome in host cells, 
but not necessarily for survival of the transduced cells or maintenance of the 
expressed genes. Nevertheless, replication-defective viruses, in which viral genes 
were partly replaced by therapeutic genes, were historically the first generation of 
‘viral vectors’ applied in gene therapy. The common types of viruses used for gene 
delivery include retroviruses (which deliver RNA), adenoviruses (which deliver 
transiently expressing double-stranded DNA), and adeno-associated viruses 
(AAVs, which deliver single stranded stably expressing DNA). Viral particles 
range in size from 25 nm (AAVs) to 60–100 nm (adenoviruses and retroviruses) 
[2]. Other viruses that were used to develop viral vectors include herpes virus, pox 
virus, and more recently lentivirus. Viruses in general are highly efficient regarding 
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cellular uptake and intracellular delivery of therapeutic genes to the nucleus. To 
facilitate internalization, the virus surface can mediate binding to specific cell–
surface receptors or to extra-cellular matrix molecules, which provides a natural 
corollary for substrate-mediated delivery [2]. Although, viral vectors provide the 
most efficient gene transfer among gene delivery vehicles, some viral vectors suffer 
from limitations on the gene size (36–38 kb) [14], others raise safety concerns [12, 
15] as they have the potential to mutate or recombine with wild-type viruses or 
cause cellular damage, provoking an immune response that can lead to clearance of 
the vector or infected cells [16]. These potential issues have led to the exploration 
of non-viral delivery methods, which provide control over the chemical and 
physical properties of the vehicle. 
 
1.2.2 Non-viral vectors 
Non-viral vectors are attractive for their safety profiles and their synthetic design 
that allows high flexibility of the formulation that can be easily modified by diverse 
chemical reactions and physical interactions. However non-viral vectors yet yield 
lower efficiencies of gene transfer relative to viral vectors [2]. Non-viral vectors 
are more flexible in terms of type and size of the delivered nucleic acids. A broad 
range of nucleic acids from small double-stranded RNA for interfering with gene 
expression up to large artificial chromosomes can be used for transfection. The 
great advantage of non-viral vectors is their low immunogenicity, since synthetic 
vectors present far less or no immunogenic proteins or peptides in comparison to 
viral vectors. An obvious weakness of non-viral vectors is their low efficiency in 
intracellular nucleic acid delivery which currently is partly compensated by 
administration of large amounts of the vectors. DNA complexes are typically 
formulated by the self-assembly of plasmid, which are circular DNA molecules, 
with cationic lipids (to form lipoplexes) or polymers (to form polyplexes). Such 
compaction has been shown to protect the nucleic acids by providing a barrier 
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against nucleases, serum factors, and liver scavengers, thus limiting certain paths of 
DNA elimination from the body [17, 18]. The cationic agents bind to DNA or RNA 
due to electrostatic interactions and form particles of nanometer range. Indeed, 
complexes of cationic polymers, such as polyethylenimine (PEI) have mean 
diameters ranging from 100 nm to 1 μm, and zeta-potentials ranging from −14 mV 
to 21 mV. While, complexes formed with cationic lipids typically have mean 
diameters ranging from 200 nm to 1100 nm, with zeta-potentials that depend upon 
the cationic lipid [5]. The quantity of cationic lipid or polymer determines the 
properties of the complex; however, increasing the amount of lipid or polymer 
leads to cytotoxicity.  
Mixing of DNA and cationic lipid results in the collapse of DNA to form a 
condensed structure—termed lipoplex—in which nucleic acids are buried within 
the lipid. The thermodynamic driving force for association of the DNA and lipid is 
the entropy increase from the release of counter ions and bound water associated 
with DNA and the lipid surface [19, 20]. The colloidal properties of lipoplexes are 
principally determined by the cationic lipid/DNA charge ratio, typically defined as 
the number of amines on the cationic lipid relative to the number of phosphate 
groups on the DNA [21]. The net charge on the lipoplex affects its interactions with 
other components present in vivo and in vitro (e.g. media, serum, extracellular 
matrix glycoproteins, mucosal secretions), which can limit the transfection 
efficiency. The main components of a cationic lipid are a hydrophilic lipid anchor, 
a linker group, and a positively charged headgroup. The lipid anchor is typically 
either a fatty chain or a cholesterol group, which determines the physical properties 
of the lipid bilayer, such as flexibility and the rate of lipid exchange [22]. The 
linker group is an important determinant of the chemical stability, biodegradability, 
and transfection efficiency of the cationic lipid. The positively charged headgroup 
on the cationic lipid is responsible for interacting with the negatively charged DNA 
and is a critical determinant of the transfection and cytotoxicity of liposome 
formulations, this cytotoxicity is believed to be attributable to lipid disruption of 
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the cellular and endosomal membranes. Lipoplexes have been formed from a 
variety of liposomal formulations, which often consist of a polyamine conjugated 
to a hydrophobic lipid tail [22]. The most used cationic lipids for gene delivery are 
DOTMA, DOTAP, and DOPE. 
Cationic polymers, instead, contain high density of primary amines, which are 
protonable at neutral pH. This high density of positive charges allows the cationic 
polymers to form stable complexes with nucleic acids. In addition to proving 
positive charges for DNA complexation, the primary amines also serve as 
functional groups with which to chemical modify the polymers with ligand and 
peptides [23]. DNA polyplexes have been created with various cationic polymers 
including PLL [24], poly-L-histidine [25], poly-L-ornithine [25], and chitosan [26]. 
The most used cationic polymers for gene delivery are Poly-L-lysine (PLL) and 
Poly(ethylenimine) (PEI). In particular, complexation with polyethylenimine (PEI) 
has been considered the gold standard in polyplex-mediated gene transfer due to 
the ability of PEI–DNA complexes to transfect many cell types with high 
efficiency in vitro [27]. PEI is the organic macromolecule with the highest density 
of protonable amine functions and is therefore ideal to condense nucleic acids into 
particles of nanometer range [28]. The condensation process of DNA with the 
polycation PEI has been studied extensively. The particle size of DNA/PEI 
complexes depends on the molar ratio of PEI nitrogen to DNA phosphate (N/P 
ratio) and on the present salt concentration. Small individual particles are formed at 
low salt concentration (< 50 mM NaCl) and/or N/P ratios above 5, whereas 
formation of large aggregated particles is observed in the presence of salt (> 50 
mM NaCl) at lower N/P ratios [29]. The net positive surface charge and an excess 
of free PEI during complex formation can prevent aggregation by repulsion of 
positive charges, whereas an increase in salt concentration reduces the hydration 
layer around the particles and promotes particle aggregation. However, PEI–DNA 
complexes have shown a limited ability to transfect certain types of cells, 
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furthermore PEI exhibits significant cytotoxicity both in vivo and in vitro [30, 31] 
and its non-biodegradability precludes repeated administration [32]. 
 
 
1.3 Intra- and extracellular barriers to gene transfer  
For successful gene delivery, gene vectors must evade the immune system and be 
transported to the cell microenvironment for internalization. In particular, gene 
vectors have to overcome a series of barriers to gain access to the membrane 
surface, cytoplasmatic compartment, and nucleus of a target cell, and translate 
transgenes into protein. As particles encounter each of these barriers, they are 
subject to a certain probability of success or failure in overcoming each [33]. The 
in vivo delivery of viral vectors is strongly hampered by extracellular barriers, 
however, they are very efficient in overcoming intracellular barriers such as 
internalization into the host cell and delivery of the therapeutic gene towards the 
nucleus. In contrast, poor intracellular delivery of the carried nucleic acid remains 
the major barrier to effective gene transfer with non-viral vectors. In particular, the 
positive charge of lipoplexes and polyplexes enables interaction with the negatively 
charged cell-surface glycosaminoglycans and promotes passive cellular 
internalization [18, 23, 34]. Although positively charged vectors like PEI 
polyplexes expose high gene transfer activity in vitro systemic administration of 
such particles is rather restricted. In addition, gene transfer at effective DNA doses 
was associated with acute toxicity. Ex vivo experiments revealed that positively 
charged polyplexes induced aggregation of erythrocytes. These adverse effects can 
be overcome by ‘shielding’ of the positive surface charge of the vectors with 
hydrophilic polymers like polyethylene glycol (PEG). PEGylation of PEI 
polyplexes prevented erythrocyte aggregation, enhanced systemic circulation time 
and reduced toxicity of polyplexes [35]. Shielding with PEG, however, also 
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reduces the overall transfection efficiency because of reduced interaction with cell 
membranes of all cells including the target cells. After cellular association to the 
target cells, vectors particles are internalized by receptor-mediated endocytosis, 
macropinocytosis, phagocytosis or related processes [36]. The steps following 
internalization of DNA complexes, endosomal escape and nuclear localization, are 
thought to be rate limiting for the transfection of many cell types. Indeed, 
internalization of the plasmid does not necessarily correlate to transfection [37]. 
Internalized gene transfer complexes are mostly found in intracellular vesicles such 
as endosomes.[23] Entrapment in endosomes is thought to be associated with 
degradation of the complexes upon endosomal acidification. Therefore, subsequent 
release of particles into the cytoplasm represents a major bottleneck to gene 
delivery [38]. However, in many cases, the complexes are able to escape the 
endosome to be released to the cytosol [27, 34], where must subsequently avoid 
degradation and be transported to the nucleus for successful gene transfer. 
For lipoplex-mediated delivery, the interaction of the lipids with the endosomal 
membrane is thought to facilitate escape of the DNA to the cytoplasm prior to its 
degradation in the lysosome. It is generally theorized that lipoplexes escape the 
endosome by destabilizing the membrane through structural changes and 
interactions of the liposomal amphiphiles with the endosomal membrane, thus 
enabling the DNA release to the cytosol [39]. Instead, it is hypothesized that 
polyplexes are able to escape the endosome via the “proton sponge effect,” in 
which the buffering capacity of the cationic polymer leads to an osmotic pressure 
increase when the endosomal pH drops, ultimately causing the endosome to rupture 
and release the polyplexes to the cytosol [40]. PEI polyplexes and free PEI have 
considerable buffering capacity, because PEI is only partially protonated at 
physiological pH. Upon intracellular delivery of the DNA particle, the natural 
acidification within the endosome triggers protonation of complex-bound and free 
PEI, inducing chloride ion influx, osmotic swelling and destabilization of the 
vesicle which finally leads to release of the polyplexes into the cytoplasm [41]. 
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However, this proton sponge effect is apparently not sufficient to release the 
majority of PEI particles from the vesicles. In particular, endosomal escape 
represents a major hurdle to efficient gene transfer with small PEI polyplexes at 
low concentrations [29]. After endosomal release DNA complexes or free DNA 
have to traffic through the cytoplasm towards the nucleus, enter the nucleus and 
expose the DNA to the cell's transcription machinery. This process is not clearly 
elucidated yet. Passive diffusion of DNA within the cytoplasm is restricted 
especially for larger plasmids [42], and free DNA can be degraded by nucleases 
within the cytoplasm. Therefore, the delivery of DNA towards the nucleus is 
supposed to depend mainly on the transport of intact complexes by microtubule or 
actin filaments [43]. The transport of DNA from the cytoplasm to the nucleus may 
be the most significant limitation to successful gene transfer. In addition to 
cytoplasmic transport limitations, the size of DNA is problematic for crossing into 
the nucleus. The nuclear pores allow free diffusion entry of only small particles ~ 
70 kDa [44]. Nuclear import of DNA or DNA complexes is another big hurdle, it 
can be facilitated by the breakdown of the nuclear membrane, which is currently 
only easily during cell division [45]. Indeed, transfection of non-dividing cells with 
PEI polyplexes was several log units less effective compared to transfection of 
mitotic cells where the nuclear envelope was broken down [43].  
 
 
1.4 Gene delivery systems 
Success of gene delivery applications is supported by gene vectors that offer 
numerous advantages into overcome the intra-extracellular barriers. However, the 
transfection procedure itself can be a critical factor dictating the transfection 
efficiency. Currently most non viral gene delivery is conducted as a bolus delivery, 
which is the conventional transfection procedure that involves preplating cells, i.e., 
the cells are allowed to attach, recover, and grow for 24 h before transfection [46]. 
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Systemic or bolus delivery, leads to the presence of vector in the target cell 
population for a short time prior clearance, aggregation, or degradation, which 
involve inefficient transfection due to mass transport issues and deactivation 
process [11]. Biomaterial-based delivery addresses extracellular barriers to enhance 
gene transfer, this delivery system can enhance gene transfer by maintaining 
consistent levels of the vector in the microenvironment of the cell and reducing the 
amount of DNA required, which can decrease cell toxicity. Numerous methods 
have been developed to provide controlled, localized, sustained, and triggered 
release of genes from biomaterials, overcoming these mass transport limitations 
[47-50]. These systems may be segregated into categories of gene activated 
matrices (GAMs), substrate-mediated delivery materials, and multilayered thin 
films. 
 
1.4.1 Polymeric gene delivery 
Incorporation of plasmids or particles within a polymeric scaffold or 
immobilization of these particles onto a surface can significantly limit the 
extracellular barriers to gene delivery [51]. In particular, polymeric gene delivery 
or GAMs has ability to provide control over the location and release profile of 
delivered genes. DNA encapsulation provides several advantages in comparison 
with bolus methods for gene delivery, such as protection of the DNA from 
extracellular barriers and degradation by serum nucleases and proteases [3]. This 
process thereby maintaining the bioactivity of the plasmid and the effective levels 
of the vector for prolonged times, extends the opportunity for cellular 
internalization and increases the likelihood of gene transfer [52]. The matrix also 
promotes the interactions between cells and plasmids , while simultaneously 
providing a 3D scaffold to maintain space [53, 54] and support the migration, 
proliferation, and differentiation of infiltrating cells. A critical aspect associated 
with the encapsulation of gene therapy vectors is that the matrix fabrication method 
14 
 
must be compatible with the vector integrity, indeed they can involve high 
temperatures, organic solvents, and the generation of free radicals or shear stresses 
that may damage the vector. Even if the vector is stably encapsulated, it can still be 
damaged by the degradation products. In these systems, where DNA was 
encapsulated, release may be accomplished by diffusion out of the scaffold and/or 
degradation of the matrix. As a result, the release profile can be tailored by varying 
the material such that the DNA is delivered rapidly as in bolus delivery or in a 
prolonged fashion over a period of months [54]. Sustained release formulations can 
compensate for vectors lost due to clearance or degradation. Delivery from most 
biomaterial systems likely occurs through a combination of vector interactions with 
the matrix and subsequent release, with the vector and material designed to regulate 
these interactions. Vector release from hydrophobic polymer scaffolds, for 
example, occurs by a sequence of polymer degradation, dissolution of the vector 
and subsequent diffusion from the polymer. While, the release from hydrophilic 
polymer scaffolds, hydrogels, has been modulated through modifying the hydrogel 
or vector chemistry. The mechanism of release can be, also, tuned to control 
whether the cells in the surrounding tissue or cells migrating into the matrix are 
targeted [53, 54]. In general, matrices that deliver via scaffold degradation limit 
gene transfer to cells that infiltrate the matrix [55], whereas diffusion-controlled 
methods maintain the ability to target cells in the vicinity of the matrix [56] due to 
the limited transport of DNA through tissue [57].  
 
1.4.2 Substrate-mediated gene delivery  
For many applications, the delivery inefficiencies may be overcome by surface 
immobilization of the vehicles. This delivery strategy, termed substrate-mediated 
delivery, solid phase delivery, or reverse transfection, mimics the natural process of 
virus binding to extracellular matrix proteins [56], immobilizing DNA-complexes 
to substrates and cells are then seeded onto these particles [51]. Placing the gene 
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vector directly within the cell's microenvironment, therefore overcoming diffusion 
and mass transport limitations associated with trafficking of nonviral complexes to 
cells [5]. In addition, surface immobilization of DNA–complexes has the ability to 
preserve complexes size observed in solution and inhibit complex aggregation, 
demonstrating that immobilization maintains vehicle activity [11] and reduces 
systemic removal, while cytotoxicity is reduced because less DNA is required to 
achieve gene transfer [10]. The preservation of vector activity and increased pDNA 
concentration in the cellular microenvironment elevates the efficiency of gene 
transfer, facilitating transgene expression levels comparable to or better than those 
achieved with bolus delivery, while delivering lower quantities of surface-
immobilized pDNA [58]. Reverse transfection involves simultaneously transfecting 
and plating cells, almost similar to procedures used for transfecting suspension 
cells. Ziauddin and Sabatini were the first to report a method for reverse 
transfection16, this process as compared with conventional transfection allows 
rapid parallel analysis of large number of genes simultaneously. Finally, substrate-
mediated delivery offers the ability to pattern the immobilization of nonviral 
complexes on surfaces, which can lead to patterned transgene expression, which is 
particularly pertinent to tissue engineering applications [51]. For substrate-
mediated delivery, the properties of the surface are critical to both immobilization 
strategies and transfection (gene transfer) efficiencies. Different strategies have 
been proposed for reverse transfection methods. Surface immobilization typically 
employs either sequential deposition of DNA or cationic lipids and polymers, or 
the adsorption of preformed DNA complexes. Initial approaches immobilized DNA 
at the surface by entrapment within gelatin, followed by the addition of the 
transfection reagent.10 Subsequently, the transfection reagent has been initially 
adsorbed to the surface, followed by addition of the DNA. 11 This latter approach 
can be extended to the adsorption of multilayer films that gradually erode to expose 
the DNA for transfection[9]. Alternatively, the vectors can be formed in solution 
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and subsequently immobilized to the substrate, it can potentially be used to 
spatially regulate gene transfer.  
 
1.4.3 Multilayered thin films 
Multilayered thin films can both provide localized delivery of plasmids in vivo [59-
65] and significantly sustain the release of a plasmid. These films have been 
created using many polyelectrolytes including PLL, PGA, chitosan, hyaluronan 
(HA), poly-(allylamine hydrochloride) (PAH), poly-(sodium-4-styrenesulfonate) 
(PSS) [66], and b-cyclodextrin [67], by alternately immersing a surface in a 
solution of a cationic molecule and in a solution of an anionic molecule in a 
process known as layer-by-layer (LbL) assembly [68-71]. The use of aqueous-
based fabrication techniques in LbL assembly prevents the need for arduous wash 
steps to remove organic solvents [68]. Methods for the alternating, layer-by-layer 
adsorption of oppositely charged polymers on surfaces provide a practical approach 
to fabricate films using a broad range of naturally occurring and biologically 
important polyelectrolytes, including DNA, often without loss of biological 
function [72]. This general approach offers precise control over the compositions 
and thicknesses of thin polyelectrolyte-based films. Gene delivery from thin films 
containing plasmids has been engineered through the use of materials that degrade 
or disassemble under physiological conditions [73]. These nanometer-scale films 
were able to spatially and temporally control the gene delivery of multiple DNA 
constructs to promote transgene expression in vitro with various cell lines [68]. A 
recent and interesting approach toward thin film disassembly and plasmid release 
involves the alteration of the charge of the assembled cationic polymers. Thus, 
multilayered thin films are capable of promoting sustained release of plasmids from 
a substrate via multiple types of degradative processes.  
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1.5 Surface interactions 
 
1.5.1 Non specific interactions 
Vector immobilization to the biomaterial surface occurs through a combination of 
nonspecific and specific interactions that can be regulated through the design of the 
material and the vector. Molecular interactions between the vector and the polymer 
dictate whether the vector will be bound or released. Non specific immobilization 
approaches typically utilize the interaction of pDNA with cationic agents, which 
have shown the ability to promote localized gene delivery and sustained release. 
Viral and non-viral vectors, which contain negatively charged DNA or RNA 
potentially complexed with proteins, cationic polymers, or cationic lipids, interact 
with polymeric biomaterials through non-specific mechanisms, including 
hydrophobic, electrostatic, and van der Waals interactions that have been well 
characterized for adsorption and release of proteins from polymeric systems [74]. 
Many materials support the adsorption of proteins to the surface, and delivery 
vectors can adsorb directly to the substrate or to the proteins that are coating the 
surface. Complexes adsorbed to the substrate were homogeneously distributed 
across the surface. Based on protein adsorption,9 vector adsorption to biomaterials 
may be characterized by (1) changes in the hydration of the surface and vector, (2) 
charge interactions between the vector and the surface, (3) structural rearrangement 
of the adsorbing vector, and (4) the solution properties from which the complexes 
adsorb. Conformational changes in the vector may contribute to irreversible 
binding that limits cellular uptake, while hydrophilic substrates, which generally 
result in reversible interactions for proteins, may facilitate cellular internalization.2 
Transgene expression by nonspecific immobilization of preformed complexes is 
dependent on the molecular composition of the vector, and the relative quantity of 
each vector component (e.g. of amines on the polymer to phosphate in DNA (N/P). 
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The quantity of immobilized complexes depended upon the charge and size of the 
DNA complexes. Transgene expression was observed on all substrates; however, 
the extent of transgene expression and the number of transfected cells were 
enhanced by precoating the substrate with serum proteins. This surface coating 
enabled homogeneously distributed complexes to redistribute to the cell surface.  
 
1.5.2 Specific interaction 
Strategies for specific immobilization include the use of complementary functional 
groups on the vector and surface, such as antigen-antibody interactions or biotin-
avidin interactions [10], to control vector binding to the substrate. Upon 
complexation, a fraction of these functional groups will be available on the exterior 
of the particle for immobilization. Similarly, viral particles can be genetically 
engineered with specific sequences for binding or chemically modified after 
formation [75]. Indeed, viral vectors have been designed that specifically interact 
with natural and synthetic biomaterials through the use of antibodies or covalent 
coupling to allow for site-specific gene delivery. Although the functional groups 
provide specific interactions between the biomaterial and vector, nonspecific 
interactions contribute to vector immobilization [76]. The effective affinity of the 
vector for the biomaterial is determined by the strength of these molecular 
interactions, which may also be influenced by environmental conditions (e.g., ionic 
strength, pH), binding-induced conformational changes, or vector unpacking. 
Biotinylated-PEI has been used to complex pDNA and sequester the complexes on 
avidin-functionalized surfaces. While these systems provide many delivery 
advantages, efficient transfection using these immobilized vehicles requires careful 
control to balance the binding of the vehicle to the substrate with the ability to 
release the vehicle for cellular uptake. The specific binding of avidin-modified 
materials to biotinylated vectors has allowed researchers to identify several key 
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design parameters for specific immobilization strategies. It was shown that 
increasing the number of biotin groups in the complex, either through increasing 
the number of biotin residues per polymer or increasing the percentage of 
biotinylated polymers in the complex, increased the binding of the complexes to 
the substrate; however, maximal transfection in vitro was achieved when only a 
small fraction of the polymer forming the complex contained biotin. Maximal 
binding occurs when there is a high affinity of the complex for the substrate, but 
this high affinity reduces transfection.18 Manipulation of the rate of vehicle release 
thus inherently requires alteration of the properties of the vehicle and/or substrate. 
Furthermore, release is not cell-specific, and will occur for any cell that comes into 
contact with the vehicle. Cellular internalization can occur through breaking of the 
linkage between the complex and substrate, degradation of the substrate, or 
disruption of the complex to allow for release.   
 
 
1.7 Aim of work 
Aim of the research object of this PhD thesis is designing a transfection platform 
for substrate-mediated delivery able to stably retain gene vectors and at same time 
mediate a efficient gene transfer. To do so the role of the interaction, in terms of 
strength and specificity, between PEI-DNA complexes and the substrate in 
substrate-mediated gene transfer has been investigated. The results of the research 
carried out have provided the feasibility of preparing substrate-mediated gene 
delivery platforms using different approaches. In particular they have highlighted 
the suitability of assemble, organize and present the DNA to the surface, promoting 
the internalization of DNA by cells in way that provide opportunities to enhance 
levels of surface-mediated cell transfection. 
The first part of the research was devoted to realization of a platform for reverse 
transfection immobilizating DNA complexes on substrate through a covalent bond. 
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The occurrence of PEI/DNA complexes on substrate and cellular uptake were 
evaluated.  
In the second part, based upon the results of the performed experiments, gene 
complexes were weakly tethered to obtain a compromise between a good efficiency 
of reverse transfection and the stability of gene vector on substrate. Indeed, DNA 
complexes have been electrostatically adsorbed at surface of the substrate for 
reverse transfection. In this case cellular uptake and transfection results indicate 
that the success of this system is due to a release of gene complexes from the 
substrate.  
The last part of the research, has been focused on the realization of a specific 
adsorption of gene particles to a protein-coated substrate. To this aim, a select 
peptide with effective affinity for fibronectin was evaluated as linker between 
coated substrate and PEI/DNA complexes. The efficiency of this system relate to 
the specificity with which PEI/DNA complexes interact with fibronectin coated 
substrate through this linker peptide is under evaluation. Furthermore, this strategy 
was implemented though the spatial protein patterning to create 
adhesive/transfective islands on substrate, for future application purposes. 
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Chapter 2 
 
Platform for gene delivery: covalent interaction 
between PEI/DNA complexes and cell-culturing 
glass substrate. 
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2.1 Introduction 
 
In recent years, the development of systems capable of controlled and efficient 
gene transfer has concerned many in vitro research and diagnostic applications. In 
particular, gene delivery from surfaces is the basis of many screening systems to 
examine the cellular response to altered gene expression within a more 
representative biological context [1, 2]. Transfected cell arrays for studies in 
functional genomics [3-5] or patterned gene delivery for models of tissue growth 
[6, 7] are examples of applications of gene delivery studies to basic research. 
Substrate-mediated gene transfer, also known as reverse transfection, has the 
potential to retain for a long period of time effective DNA levels in a constrained 
area, avoiding the possibility of dispersion, extending the opportunity for cellular 
internalization and increasing the likelihood of gene transfer [8]. This delivery 
method involves the immobilization of DNA to a substrate that supports cell 
adhesion placing the vector directly in the cell microenvironment, reducing mass 
transport limitations and localizes delivery [9]. However, if the association of gene 
particles with a substrate is too tight, endocytic uptake and transfection can suffer 
[10]. In order to obtain a successful reverse transfection system, the interaction 
between substrate and gene vector must be sufficiently strong to immobilize and 
maintain the vector at the surface, while allowing for cellular internalization. 
Substrate and vector properties mediate the vector-surface interactions that are 
determinants of binding and gene transfer [11, 12]. The context wherein 
immobilized DNA-vector complexes are presented to cells can be modified with 
surface chemistry. A bioactive compound can be immobilize to a polymeric surface 
through various methods such as (i) adsorption via electrostatic interactions, in 
which complexes physically adsorbed onto the substrate were spontaneously and 
gradually desorbed from the surface during cell cultivation [13], (ii) ligand–
receptor pairing, such as biotin–avidin, the strongest reported non-covalent bond 
[14] and (iii) covalent attachment. The latter offer several advantages by providing 
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the most stable bond between the compound and the functionalized polymer 
surface. The covalent immobilization of bioactive compounds has seen rapid grown 
in the past decade with applications in various fields [14, 15]. In the biomedical 
field, a covalent immobilization can be used to extend the half-life of a biomolecule 
or prevent its metabolism, as in compounds which provide anti-tumor activity 
when used locally, but may be toxic if metabolized [16]. Several polymers have 
been selected as substrates for biomolecule immobilization but, because of their 
inert nature, they must undergo surface functionalization, by introducing reactive 
functional groups, prior to attachment of a bioactive compound. Different surface 
modification strategies have been developed to improve wetting, adhesion, and 
printing of polymer surfaces by introducing a variety of polar groups, with little 
attention to functional group specificity. However, when surface modification is a 
precursor to attaching a bioactive compound, these techniques must be tailored to 
introduce a specific functional group [17]. Tethering a bioactive compound to a 
solid substrate via a spacer molecule, can also improve bioactivity by reducing 
steric constraints and shielding the compound from hydrophobic surface induced 
denaturation. In the same way, also binding of gene complexes to glass substrates 
for culturing cells requires surface modification. In particular, the covalent 
attachment of a bioactive compound to a glass surface involve glass pre-treatment 
and surface activation, commonly using silane [18]. Normally, vinyl silane or 
methacrylate silane was used as a coupling agent, because it contains at least one 
functional group with double bond, which can readily react with organic polymer, 
and functional groups that react with silanol groups on the glass surface [19]. It acts 
as a compound that provide at the interface of dissimilar materials in a composite, a 
stable bond resulting in improved composite properties and preservation of these 
properties. 
In this chapter was investigated the stability and bioactivity of PEI/DNA 
complexes covalently bound to a glass substrates. In order to tether DNA 
complexes to glass slides, functional groups were introduced both on gene vector 
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and substrate. In particular, glass surface was activated with a methacrylate silane 
monolayer and PEI/DNA complexes were functionalized through modification of 
PEI molecules with acrylated PEG The changes of substrate and complexes 
properties were characterized and the occurrence of complexes on substrates after 
binding photoreaction was been investigated. Furthermore the efficiency of this 
system was evaluated respect to the cellular response to interaction with bound 
complexes. 
 
 
2.2 Materials and Methods 
2.2.1 Materials  
 
Linear Polyethylenimine (L-PEI) with an average molecular weight of 25 kDa was 
purchased from Polysciences (Warrington, PA). Tetramethylrhodamine-conjugated 
linear PEI (JetPEI-fluoR) was purchased from Polyplus-transfection SA (7mM 
ammine content, Illkirch, France). Acryloyl-PEG-N-hydroxysuccinimmide (Ac-
PEG-NHS, 3.4kDa) was purchased from Creative PEG Works (Winston-Salem, 
NC, USA). 3-aminopropyl triethoxysilane (APTES) and 3-(Trimethoxysilyl)propyl 
methacrylate (TMSPMA) were purchased from Sigma Aldrich (St. Louis, MO, 
USA). The reporter plasmid encoding for enhanced green fluorescent protein 
(p
CMV
EGFP) driven by a cytomegalovirus (CMV) promoter was amplified in DH5α 
competent Escherichia coli strain, extracted and purified from bacterial culture 
using Qiagen plasmid kit (Santa Clara, CA) and stored in Tris-EDTA buffer 
solution. Transfection studies were performed with NIH/3T3 mouse fibroblasts 
cultured in a humidified 5 % CO2 atmosphere at 37 °C in Dulbecco’s modified 
Eagle medium with 4.5 g L
-1
 glucose (DMEM) (Gibco) supplemented with 10 % 
Bovine Calf Serum (BCS) (Gibco), 4 mM glutamine, 100 U mL
-1
 penicillin and 0.1 
mg mL
-1
 streptomycin in a 100 mm diameter cell culture dish (Corning, NY, USA). 
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Plasmid DNA (p
CMV
EGFP) was labeled with the cyanine dye Cy5 using Label IT® 
Tracker™ Intracellular Nucleic Acid Localization Kit purchased from Mirus Bio 
(Madison, WI, USA). 
 
2.2.2 Plasmid DNA labeling  
Plasmid DNA, p
CMV
EGFP, was labeled with cyanine dye Cy5 using Label IT® 
Tracker™ Intracellular Nucleic Acid Localization Kit (Mirus Bio, Madison, WI, 
USA). Briefly, 20 μg of plasmid DNA was mixed with 10 μl of reagent in a total 
volume of 300 μl, followed by incubation for 1 h at 37 °C according to the 
recommendation by the supplier [20]. After 0.1 volumes of 5 M NaCl were added 
and Label IT reagent was removed by overnight precipitation with 2 volumes of 
ice-cold absolute ethanol at – 20 °C. The labeled DNA was recovered by 
centrifugation at 13,000 rpm for 15 minutes. The pellet was washed with 70% 
ethanol and resuspended in molecular biology grade water. The purity was 
monitored by measuring the ratio of absorbance at 260 nm and 280nm 
(A260nm/A280nm) at NanoDrop 2000 UV-Vis Spectrophotometer. 
 
2.2.3 Synthesis of acryloyl-PEG-PEI conjugate 
Ac-PEG-PEI copolymer was synthesized by combining 0.7 μmol of linear PEI (25 
kDa, Polyscience) dissolved in 1 ml of 0.25 M NaCl with 0.8 ml of H2O containing 
2 μmol of acryloyl-PEG-N-hydroxysuccinimide (3.4 kDa, Creative PEG Works). 
The solution was magnetically stirred at room temperature overnight and 
subsequently loaded on a Macro-prep (Macro-prep High S; HR 10/10, BioRad, 
München, Germany) and fractionated with a salt gradient from 0.5 to 3.0 M NaCl 
in 20 mM HEPES at pH 7.1. The product was eluted between 2.4 and 2.9 ml M 
NaCl. The PEG-PEI conjugate was dialyzed against 2 l HBS (20 mM HEPES pH 
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7.3, containing 150 mM NaCl). The conjugate was diluted to 10 μg ml–1 by the 
addition of HEPES buffer at pH 7.3, and then stored at - 20 °C. The modification of 
PEI with PEG in the reaction product was determined from proton nuclear 
magnetic resonance spectrometry (
1
H-NMR) (400 MHz, Varian) using deuterated 
water (D2O) as solvent. The degree of PEG substitution was determined by 
comparing the integral values obtained from the number of CH2CH2O protons of 
PEG and CH2CH2NH protons of PEI [21-23]. 
 
2.2.4 PEGylated complexes formation  
DNA complexes were formed by addition of cationic polymer (PEI) to plasmid 
resulting in self-assembled colloidal particles [24]. For PEG-PEIpDNA complexes 
formation, tetramethylrhodamine-conjugated linear PEI (jetPEI-fluoR 7 mM amine 
content, Polyplus-Transfection, Illkirch, France) and Ac–PEG-PEI copolymer were 
added dropwise to plasmid DNA solution. Both polymer and plasmid solutions 
were diluted in 150 mM NaCl, mixed and incubated for 20 minutes at room 
temperature to allow complex formation between the positively charged PEI 
(amine groups) and the negatively charged pDNA (phosphate groups) [25, 26]. 
Complexes generated using different N (nitrogen) to P (phosphate) ratios (N/P), 
molar ratio of amine groups of PEI to phosphate groups in pDNA backbone and 
amounts of PEG molecules, were tested.  
 
2.2.5 Characterization of DNA complexes: size, zeta-potential and bioactivity  
 
In order to optimize the complexes formulation, in terms of best transfection 
efficiency and lower cytotocixity, PEI/DNA and PEGylated complexes were 
characterized. The particle size and zeta-potential of the complexes were carried 
out by dynamic laser light scattering using a Zetasizer Nano-ZS (Malvern 
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Instruments, Worcestershire, UK). To formed PEI/DNA complexes at different N/P 
ratios (5, 6 and 10), stock PEI and DNA solutions were prepared and complexes 
generated by varying the PEI amounts and maintaining constant the pDNA 
concentration. Then PEGylated complexes were prepared, fixing the N/P ratio at 5 
and varying Ac-PEG-PEI copolymer amounts. All measurements were done in 
triplicate, the mean value was recorded as the average of three different 
measurements. 
Transfection efficiency and cellular cytotoxicity of the DNA complexes, generated 
according to the different formulations, were tested performing 2D transfection 
analysis. For transfection experiments, NIH3T3 cells were seeded in 35 mm 
polystyrene Petri dishes (Corning, Corning, NY, USA) at density of 100,000 
cells/dish and incubated at 37 °C and 5 % CO2, prior to ~80 % confluence, when 
polymer/DNA complexes containing 3 μg plasmid DNA were added to each well. 
After 48h, samples were fixed with 4% paraformaldehyde (Sigma Aldrich) for 15 
min at RT and stained using 40,6-diamidino-2-phenylindole (DAPI) (Sigma-
Aldrich) (maximum excitation at 358 nm; maximum emission at 461 nm) for 
nuclei detection. The 40,6-diamidino-2-phenylindole stock solution (10 mg ml
-1
 in 
dimethyl sulfoxide) was diluted in PBS (110
-4
 v/ v), incubated for 10 min at 37 °C, 
and then rinsed three times with PBS. Analyses of the transfection were carried out 
using a confocal laser scanning microscope CLSM (Leica TCS SP5 II) equipped 
with a 25 X objective and a 2P (two-photon)-mode, 700nm laser line emitted by a 
Coherent Chameleon Ultra Laserand and argon laser lines at wavelengths 488 nm. 
Image resolution was fixed to 1024 X 1024 pixels. The emitted fluorescence was 
detected between 420 and 480 nm and between 500 and 530 nm, through different 
detector channels. Transfection efficiency (number of transfected cells (GFP-
expressing cells)/number of cells (DAPI-stained cells)) were quantified through 
analysis of images using Image J software. Each estimation was repeated in 
triplicate on different samples. Results were compared by analysis of variance 
(ANOVA), and a significance level of 95% (P = 0.05) was chosen in all cases. 
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The biocompatibility of DNA complexes generated according to different 
formulations was evaluated by colorimetric Alamar blue assay (Life Technologies, 
Grand Island, NY) according to the manufacturer’s procedure [27, 28]. After 24 h 
of incubation in a humidified atmosphere at 37 °C and 5 % CO2, NIH3T3 cells 
seeded onto 24-well plates at an initial density of 25,000 cells/well, were treated 
with complexes suspensions with different formulations, N/P ratios and Ac-PEG-
PEI amounts. The experiments were performed in triplicates and non-trasfected 
cells were used as a negative control. The metabolic activity of all cell cultures was 
determined after 1 and 2 days of exposure by using standard Alamar Blue assay. 
Absorbance of Alamar Blue reagent solution was read at 570 nm and 600 nm by a 
plate reader (Enspire 2300, Perkin-Elmer). Data represent the cell viability 
percentage of treated cells normalized to non-treated cells. All experiments were 
performed in triplicate.  
 
2.2.6 Modification of glass substrates  
 
Glass coverslips of 12 mm Ø (Knittel glass, Germany) were used to covalently 
bind PEGylated complexes. In order to provide bonding sites (double bonds) for 
the polyplexes onto the glass surface, 12 mm diameter glass coverslips were treated 
with two silane solutions. 3-(trimethoxysilyl) propyl methacrylate (TMSPMA, 
Sigma Aldrich, St. Louis, MO) and 3-aminopropyl triethoxy silane (APTES, Sigma 
Aldrich, St. Louis, MO) were co-immobilized to the glass coverslips by silane 
condensation. Prior to modification, the glass coverslips were cleaned carefully by 
washes with detergent and deionized water, in addition, to remove any surface 
impurities the slides were immersed in ethanol and ultrasonicated for 10 min and 
then dried in a nitrogen flow. Next, the substrates were exposed to oxygen plasma 
excitation for 3 min in a cleaning chamber Plasma Femto (Diener, Bӧblingen, 
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Germany) equipped with a 13.56 MHz 100W generator and then treated by 
immersing with a 0.5 % v/v solution of TMSPMA and APTES in 95% ethanol for 
5 minutes. After the silane treatment glass coverslips were extensively rinsed with 
ethanol to remove residual reagent and dried under a vacuum for 2 h.  
 
2.2.7 Water contact angle  
 
Surface modification of glass slides by silane immobilization was analyzed by 
water contact angles measurements of water in air at room temperature under static 
conditions. An Attension Theta optical tensiometer (Biolin Scientific, Stockholm, 
Sweden) was used to analyze the different wettability of modified substrates in 
order to verify to the occurrence of chemical modification. An amount of 4 μL 
droplets of MilliQ water were applied on chemically modified glass surfaces and 
the pictures was taken with a digital camera. Contact angle was recorded as the 
angle between the point of contact of the droplet with the solid surface and a 
tangent with the droplet profile. The contact angle measurement was estimated 
from a picture and calculated as the mean value of 3 separate measurements, the 
standard deviation of measurements was < 3°. 
 
2.2.8 Binding of PEGylated complexes to modified glass substrate 
 
Through the activation of glass slides with TMSPMA and APTES silane, 
methacrylate groups were exposed at surface to allow the photocrosslinking of Ac-
PEG-PEIpDNA complexes. In order to induce a covalently bind PEGylated 
complexes to activated glass slides, modified complexes mixture and 1.5 % (v/v) of 
a photoinitiator (Irgacure 2959 Ciba, Switzerland) was rapidly exposed to long-
wavelength UV light (365 nm, 10mW cm
-2
, 1 min). After photoreaction between 
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exposed acryloyl groups, unbound complexes were removed and the substrates 
were washed twice with 1 X phosphate buffered saline (PBS). The occurrence and 
distribution of Ac-PEG-PEIpDNA complexes on activated glass substrates were 
analyzed initially by fluorescence microscopy, through the detection of Cy5 labeled 
plasmid DNA and rhodamine labeled PEI. Leica TCS SP5 MP, equipped with a 
25X water immersion objective was used to acquire images with a resolution of 
512 x 512 pixels. Emitted light was detected with two photomultipliers through 
selected band pass filters. Excitation of rhodamine-labeled PEI, was achieved using 
the 543 nm excitation line, with the resulting fluorescent wavelengths observed 
using a 560 - 610 nm band pass filter and excitation of pDNA-Cy5 was achieved 
with the 633 nm excitation line, with the resulting fluorescence observed using a 
650 - 750 nm band pass filter.  
 
2.2.9 Characterization of substrates 
 
To examine the surface modifications and bound complexes morphology atomic 
force microscopy (AFM) was used. The PEGylated polyplexes was prepared and 
bind on activated glass slides by photoreaction, as described above. After 
complexes binding process, surfaces were rinsed with 1 X PBS and with two 
additional washes in Milli-Q water, to remove any traces of salt on the surface then 
the samples were allowed to dry in air before imaging. AFM experiments were 
carried out in “dry” conditions with a BioAFM NanoWizard II (JPK Instruments, 
Berlin, Germany). Images at 1024 x 1024 pixel resolution were collected at a scan 
rate of 1 Hz in air at room temperature in contact mode using a silicon nitride tip 
with a nominal spring constant of 0.01 N m
-1
 (MLCT, Bruker, Billerica, MA, 
USA). At least three independent imaging scans were obtained for each sample to 
obtain a representation for each surface.  
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Substrates and bound complexes morphology was investigated by scanning 
electron microscopy (SEM), too. Prior to imaging, dried samples were mounted to 
microscope stub and sputter coated with 5 nm of platinum-palladium under an 
argon atmosphere using a SEM coating system (Cressingthon, 208 HR, UK). 
Samples surface morphology was then observed and images were taken using 
scanning electron microscope (Zeiss, FEG Ultraplus, Germany) with an 
accelerating voltage of 8 kV and variable magnifications. 
 
2.2.10 Binding efficiency  
 
In order to monitoring the amount of DNA complexes immobilized to the surface 
after binding reaction, Cy5 labeled plasmid was used. DNA concentration in 
solution before and following binding reaction was estimated through measures of 
fluorescence at 633 nm in a multi-well plate spectrofluorometer (Enspire 2300, 
Perkin Elmer), via a standard curve. Complexes binding efficiency was calculated 
as the difference between the DNA complexes concentrations, before [Ci] and after 
[Cf] photoreaction, normalized to initial concentration, in percentage  
 
     
  
     
 
The density of the complexes bound to each activated glass slides was established 
by normalizing the amount of the covalently bound complexes to total area of the 
substrate.  
To evaluate the complexes release from substrates, after efficiency binding tests 
400 μl of conditioned medium (cDMEM) were added at the samples and incubated 
at 37 °C and 5 % CO2. At scheduled time intervals (24, 48 and 72 h) cDMEM was 
removed and PEG-PEIpDNA-Cy5 complexes concentration was detected via a 
standard curve, by measuring the fluorescence at 633 nm, as described above. The 
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percentage of PEG-PEIpDNA complexes released was calculated with respect to 
the immobilized amount. Binding and release efficiency results were compared by 
analysis of variance (ANOVA) with a significance level of 95% (P = 0.05). 
 
2.2.11 Quantification of internalized complexes  
To investigate cellular interaction with covalently bound complexes, the amount of 
DNA complexes internalized by the cells after incubation on modified substrates 
was evaluated. To this aim, PEGylated complexes, generated using Cy5-labeled 
plasmid DNA, were covalently bound at activated glass slides, as described above. 
Immediately following complexes binding, NIH3T3 cells were plated on these 
modified glass substrates at a density of 7000 cells cm
-2
, and incubated in culture 
medium at 37 °C and 5 % CO2. After scheduled times, cells were roughly rinsed 
with 1 X PBS, collected via trypsinization, and reseeded on glass dishes 
(Fluorodish, World Precision Instruments Ltd). After 24h, cells were fixed using 4 
% paraformaldehyde (PFA, Sigma Aldrich) for 15 min at RT and observed with a 
laser scanning confocal microscope (CLSM). An inverted confocal microscope 
(Leica TCS SP5 II), equipped with a 63X 1.2 NA oil immersion objective was used 
for the optical sectioning of cells. Excitation of rhodamine-labeled PEI and pDNA-
Cy5 was achieved using, respectively, the 543 nm and 633 nm excitation line, 
while the emitted fluorescence was detected between 550 and 610 nm for 
Rhodamine-PEI detection and 650 and 750 nm for DNA-Cy5 detection, through 
different detector channels. Image resolution was fixed to 1024 x 1024 pixels. The 
intracellular fluorescence of the internalized complexes at different time point was 
quantified using ImageJ software. Data were reported as the percentage area of the 
internalized complexes divided by total cellular area. In particular, cell area was 
evaluated by using plug in Analyze Particles of ImageJ software. At least 15 cells 
were collected and analyzed for each time point and each substrate. 
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2.2.12 Complexes intracellular fate_Lysosome co-localization 
 
In order to investigate the intracellular fate of internalized complexes, in particular 
to localize the polyplexes inside cellular lysosomes, Lysotracker Red DND-99 
(Molecular Probes, Invitrogen) was used on non fixed cells following 
manufacturer’s procedure. Briefly, lysosomal compartments were visualized by 
incubating cells with 0.5 mL Lysotracker Red for 30 min at room temperature prior 
to confocal microscope acquisition. Co-localization experiments were performed 
both on cells on complexes modified substrates and on cells detached from 
substrates and reseeded on fluorodish. The co-localization with PEG-PEIpDNA 
complexes labeled with Cy5 and subcellular compartments marked with 
Rhodamine, was assisted by an inverted Leica SP5 confocal microscope. Live cells 
were imaged through a 63X oil-immersion objective, the resulting image resolution 
was 1024 X 1024 pixels. Cy5-labeled plasmid DNA was excited by a HeNe laser at 
633 nm and fluorescence was observed at 650–750 nm. Lysosomal compartments 
were visualized through excitation by a HeNe laser at 543 nm and fluorescence was 
observed at 550–610 nm. Cy5-DNA complexes and lysosomes-Rhod were imaged 
by confocal microscopy and the colocalization of DNA plasmid in lysosomes was 
quantified using NIH ImageJ JACoP plugin. By this procedure Pearson’s 
coefficient was calculated in order  to estimate a correlation index [29]. At least 17 
cells were captured and analyzed per condition.  
 
2.3 Results and Discussions 
2.3.1 PEG-PEI conjugate: NMR characterization  
 
The modification of PEI with PEG was assessed by 
1
H-NMR spectroscopy in D2O. 
The degree of PEG substitution of linear PEI (25 kDa) with PEG (3.4 kDa) was 
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determined by comparing the peaks of CH2CH2O protons of PEG ( 3.58 ppm) and 
CH2CH2NH protons of PEI (2.5 – 3.1 ppm). Results of spectra integration (Figure 
1) indicate that the molecular ratio between PEG and PEI in the copolymer is about 
60 : 40, therefore, considering the respective molecular weights, in the PEG-PEI 
conjugate produced each PEI macromolecule was modified with 5 blocks of PEG 
[30].  
 
Figure 1 1HMNR spectrum of PEG-PEI copolymer in D2O. The peaks at 3.6 ppm was assigned to 
protons of PEG and the peaks between 2.7 – 2.9 was assigned to protons of PEI. The ratio of PEG/PEI 
molecules in the copolymer was estimated using integral values 
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2.3.2 Complexes characterization  
 
To compare different formulations of PEG-PEIpDNA complexes, in terms of N/P 
ratio and amount of PEG molecules, size, charge, transfection and cellular 
cytotoxicity of complexes were initially characterized. Particles size and surface 
charge dictates the interaction of complexes with the cells thereby leading to uptake 
and efficient transfection [31]. DLS measurements indicate that the complexes 
diameter, formed at N/P ratio of 5, 6 and 10, ranging from 110 to 150 nm, while 
zeta potential was about 27 ± 1.3 mV (Table 1). The polydispersity index (PDI) 
was approximately 0.1, thus indicating narrow size distribution, high uniformity in 
particle size distribution and overall general homogeneity of the sample. The size 
and surface charge of the complexes are both important parameters for their 
interaction and entry into cells [32, 33].  
 
Table 1 Size and zeta potential of polyplexes formulated at N/P ratio of 5, 6, 10. 
 
 
With particular regards to the surface charge, a balance between the maximal 
transfection efficiency and the amount of cell death associated with transfection is 
required [34]. Transfection efficiency and citotoxicity of complexes was evaluated 
performing 2D transfection analysis on NIH3T3 cells with complexes at N/P ratio 
of 5, 6 and 10. As shown in fig. 2a, the complexes formed at three different N/P 
ratios have almost the same transfection efficiency (40%), but the cytotoxicity of 
N/P ratio Size (d.nm) Z-potential
(mV)
5 114 ± 6.3 27 ± 2
6 145 ± 7 28 ± 0,5
10 108 ± 1 25 ± 1
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the complexes increase with the N/P ratio (fig. 2b). Taking in account these results, 
subsequent substrate-mediate delivery experiments were conducted using 
complexes formed at N/P ratio of 5, that have shown not much affect the cellular 
viability.  
 
 
 
Figure 2 Bioactivity of PEI/DNA complexes generated at N/P ratio of 5, 6 and 10. a) Transfection 
efficiency, by NIH3T3 cells treated with free polyplexes formed at various N/P ratios and b) cytotoxicity 
of complexes as function of N/P ratio. 
 
 
In order to bind gene complexes at a substrates, PEIpDNA complexes were 
functionalized through the introduction of acryloyl-PEG molecules. Clamme J. P. 
et al., found that at the molar ratios of PEI nitrogen atoms to DNA phosphate 
usually used for transfection, ~ 86% of the PEI molecules were in a free form and 
the PEI/DNA complexes are composed on the average by 3.5 (± 1) DNA plasmids 
and ~ 30 PEI molecules [35]. Therefore, we have formulated the PEGylated 
complexes varying the ratio between the amount of linear PEI (jetPEI-fluoR) and 
Ac-PEG-PEI copolymer, containing about 5 PEG molecules for each PEI 
macromolecule (NMR results), and, based on a theoretical estimation, calculate the 
number of PEG molecules for complex. Results of DLS measurements indicate that 
PEGylation appeared to prevent the size increase (Table 2), rather the diameter of 
the PEGylated complexes decreases with the increase of the PEG molecules, as 
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previously reported by most research groups [21]. In general, no remarkable 
differences in zeta-potential were noted between particles, except for complexes 
formed with the highest PEG substitution, which demonstrates that PEG molecules 
mask the positive charge of the PEI molecules, reducing the positive charge 
exposed at the surface. As expected, the PEGylation leads to a decrease of 
complexes toxicity [36-38]. The cytotoxicity, calculated as cell viability percentage 
of treated cells normalized to non-treated cells, has been found to be dependent on 
the interaction of the PEI/DNA complexes with cell membranes which increases 
with positive charges exposed on the surface.[39] In particular, the polycationic 
polymers (like PEI) undergo strong electrostatic interaction with plasma membrane 
proteins, which can lead to destabilization and ultimately rupture of the cell 
membrane. Fischer et al. demonstrated that the cytotoxicity of different types of 
polycationic polymers depend on the number and arrangement of the cationic 
charges which determines the degree of interaction with the cell membranes and 
the cells exposed to cationic polymers first show membrane leakage followed by a 
decrease in the metabolic activity [39]. In our case, the addition of PEG molecules, 
hiding the positive charge at surface of the PEGylated complexes, cause an 
increase of the cellular viability and, at same time, a decrease of the cellular uptake 
and consequently of transfection efficiency (Table 2). Transfection, calculated as 
the number of transfected cells (GFP-expressing) normalized on total number of 
cell (DAPI-stained), evaluated through by confocal images was higher with 
complexes generated with low amount of PEG molecules. 
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Table 2 Characterization of PEGylated complexes formed at N/P 5 varying the number of PEG molecules. 
Results of DLS measurements, transfection efficiency as percentage of NIH3T3 cells expressing GFP and 
cytotoxicity of PEGylated complexes generated with different amounts of PEG-PEI copolymer. 
 
 
2.3.3 Characterization of complexes activated substrates  
 
Surface modifications were widely characterized by contact angle, AFM, SEM and 
confocal microscopy. Fig. 3 depicts a synthesis scheme for preparing the activated 
substrate. First, the surface of glass slides were activated by oxygen plasma 
treatment and chemically modified with a silane condensation of 
Trimethoxysilylpropyl methacrylate (TMSPMA), having a acryloyl group and 3-
aminopropyl triethoxysilane (APTES) having an amino group (Fig. 3b). Finally, 
PEGylated complexes, formed as described in materials and methods section (Fig. 
3a), were bound to modified glass substrates via a specific photocrosslink reaction 
between the respective acryloyl groups (Fig. 3c). To achieve practically sufficient 
complexes binding (spatial group) APTES silane was co-immobilized with 
TMSPMA on glass surface [13]. 
 
 
PEG molecules for
PEGylated complex
Size (d. nm) Z-potential
(mV)
Transfection
efficiency (%)
Cellular
viability (%)
5 105 ± 4 23 ± 8 24 ± 3 16 ± 3
10 113 ± 14 27 ± 8 23 ± 5 16 ± 5 
30 87 ± 6 27 ± 8 17 ± 4 25 ± 11
75 98 ± 24 25 ±8 18 ± 6 25 ± 7
150 96 ± 5 23 ± 2 2 ± 1 29 ± 10
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Figure 3 Synthetic scheme of preparation of complexes modified substrates. a) PEGylated complexes 
formation, b) Chemical activation of glass slides c) Covalent binding of PEGylated complexes with 
activated glass substrates through a photo-reaction  
. 
 
 
Chemical modification of the glass surface was confirmed by water contact angle 
measurements. The quality of the surface treatment was checked by the difference 
in contact angle of water on silanized and unsilanized glass surface, used as a 
reference and prepared in exactly the same manner, using equal type of glass, same 
washing, drying protocol and same type of pre-treatment. Results are shown in 
Table 3, the TMSPMA and APTES silane coupling treatment decrease the 
TMSPMA, 
APTES
PLASMA 
TREATMENT
OH
OH
OHOH
OH
OH
a)
b)
c)
1,5% Photoinitiator
1’ UV Light
PEG-PEI-DNA 
complexes
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wettability of the surfaces of glass slides, giving rise to increase in contact angle 
from 63° ± 1 of the unsilanized glass slides to 76° ± 3 for the glass slides activated 
with functional groups [40]. Higher the contact angle, higher the hydrophobicity, 
higher the amount of the present double bonds and consequently higher strength of 
attachment is expected.  
 
 
 
Table 3 Water contact angle measurements on silanized and unsilanized glass slides 
 
 
Occurrence and persistence of the complexes on the substrates was analyzed, to 
begin with confocal microscopy due to the presence in the complex of both labeled 
DNA and PEI. Confocal images show both signals of PEI-Rhod and DNA-Cy5 on 
substrates, in particular, fig. 4c shown the merge of a and b images and highlight 
the correspondence of both signals on substrate after binding process. 
 
 
 
Figure 4 CLSM images of PEGylated complexes tethered to activated glass substrate. (A) PEI-Rhod, (B) 
DNA-Cy5, (C) merge of A and B images. 
Glass slides Silanized glass slides
Contact angle 63° ± 1 76° ± 3
100 μm
a) b) c) 
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Complexes modified glass substrates was characterized, also using atomic force 
microscopy. AFM has proven to be an excellent tool to image soft biological 
structures and can be performed after complex deposition on a surface, with high 
resolution [9]. AFM images were obtained by scanning glass slides with 
immobilized complexes and representative images (Figure 5) revealed the 
representative globular morphology of PEGylated complexes on activated 
substrates [36, 41, 42]. Moreover, the feature height of the bound complexes was 
similar at the typical diameter of PEGylated complexes, this observation highlight 
the absence of aggregation of complexes on substrates during the binding process. 
Previous studies examining complexes using AFM, typically on mica substrates, 
reported a range of complex morphologies similar to the results presented here. 
PEGylated PEI–DNA complexes analyzed by AFM had defined, spherical 
complexes [30–32], with less aggregation and smaller diameters than similar 
complexes without PEG, but were also demonstrated to be less uniform.  
 
 
 
Figure 5 Atomic force microscopy images at different magnifications of PEGylated complexes bound to 
activated glass substrates  
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Morphological features of complexes modified substrates by scanning electron 
microscopy (SEM) clarified the distribution of the complexes on substrates and, in 
particular, highlighted the circular morphology of the bound complexes (Figure 6). 
 
Figure 6 SEM image of PEGylated complexes bound to activated glass substrate 
 
 
2.3.4 Binding efficiency  
 
Complexes binding efficiency was performed by fluorescence measurements of 
DNA-Cy5 complexes solutions before and after binding process. For each 
experimental concentrations tested the percentage of PEGylated complexes bound 
at activated substrates was about 30 – 40 % concerning the initial amount of DNA 
complexes put in contact with substrate before photoreaction. Initial DNA 
concentration and the concentration of the unbound complexes after binding 
process were showed in the Table 4. Increasing the initial complexes concentration, 
the efficiency of process decreases, maybe due to aggregation effects between 
complexes which prevent the surface binding. Therefore, density of DNA 
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complexes immobilized to the surface ranged from 0.09 μg cm-2 to 0.5 μg cm-2, but 
depends on the concentration with which have prepared the complexes.  
 
 
Table 4 Binding efficiency of PEGylated complexes to activated glass substrates. Ci complexes 
concentration initially measured, Cf complexes concentration of unbound complexes after binding 
process 
 
The quantity of surface associated DNA and the stability of the interaction between 
the complexes and surface was subsequently measured using CLSM. Analysis of 
fluorescent images, taken after the initial incubation of labeled complexes on the 
surface and after each scheduled incubation times, not shown reduction of the 
fluorescence (Figure 7). These release tests indicate that during the trial time (0 up 
to 48h), the quantity of surface-associated DNA not change.  
Ci (ng/μL) μg DNA Cf (ng/μL) Binding Efficiency (%) Surface Density
(μg/cm2)
3 0.24 2 34 0.09
6 0.5 4 36 0.18
10 0.84 6 36 0.3
12 1 8 38 0.4
17 1.5 12 30 0.5
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Figure 7 Analysis of fluorescence intensity of DNA-Cy5 complexes immobilized on substrates 
 
 
2.3.5 Internalized complexes and subcellular distribution  
 
To investigate the cell-substrate interaction, the amount of DNA complexes 
internalized by the cells after incubation on this complexes modified substrates was 
evaluated. Quantification of the internalized complexes from cells seeded on 
modified substrates was assessed using Cy5-labeled plasmid DNA to formed 
PEGylated complexes. To distinguish easily DNA-Cy5 complexes inside or outside 
the cells present on substrate, after 24h culture on bound complexes, NIH3T3 cells 
were detached from this functionalized substrates and reseeded on inert dish. 
Fluorescence of intracellular complexes was monitored the in time by confocal 
microscope acquisition and the percentage area of the cells occupy by internalized 
complexes was calculate through the images elaboration using Image J software. 
Results are shown in figure 8, comparing samples and controls, the complexes 
percentage internalized from surface are much lower than bolus delivery. Nearly all 
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cells on surfaces with immobilized complexes had internalized DNA, but not 
statistical difference of the number of complexes internalized in time was detected. 
In particular, the percentage area of transfected cells occupied by complexes, 
obtained only with bolus delivery, was approximately twenty time higher of 
complexes internalized with substrate-mediated delivery. Maybe, there is an 
hypothetical minimum threshold of internalized complexes that provides the 
transfection. Monitoring the internalization process, the percentage of the 
internalized complexes from substrates not change over time, likewise for the 
complexes internalized with bolus delivery. These results indicate a low 
internalization efficiency probably due to a low density of complexes immobilized 
to the substrate for reverse transfection.  
 
  
Figure 8 Quantification of internalized complexes by the cells seeded on modified substrates. Percentage 
cellular area occupied by internalized complexes during time. Blue bar for bolus delivered complexes, red 
bar for cells expressing GFP and green bar for substrate-mediated delivered complexes  
 
 
To investigate the intracellular fate of the internalized complexes, subcellular 
distribution was subsequently characterized. In particular the co-localization of 
DNA complexes with lysosomes compartments was analyzed by confocal 
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microscopy, and quantified using NIH ImageJ software. For substrate-mediated 
delivery, the mean percentages of lysosomal DNA is more relevant than bolus 
delivery. In the table 5 were reported Pearson’s coefficients obtained by ImageJ 
JACoP plugin for the different delivery systems in order to evaluate a correlation 
index (< 0.5 low correlation index, >0.5 high correlation index) . The values of 
Pearson’s coefficients highlight the difference between complexes delivered 
through bolus and substrate-mediated delivery, and suggests that the internalization 
pathway or cellular trafficking can differ for polyplexes delivered from the surface 
relative to bolus.  
 
Table 5 Pearson’s coefficient values. 
 
 
Pearson’s 
coefficient
Sample: cells on substrate 0,57 ± 0,11
Detached & reseeded cells 0,66 ± 0,1
Ctrl_free complexes 0,37 ± 0,1
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Figure 9 CLSM images of co-localization of Cy5 labeled plasmid with lysosome a) cells on dishes with 
free complexes b)cells on bounded complexes c) cells detached from modified substrate  and reseeded on 
inert dish. blue spots indicate Cy5-plasmid, red spots indicate lysosome 
  
a) b) c) 
20 μm
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Chapter 3 
 
Reverse transfection by PEGylated complexes adsorbed to 
a solid substrate: role of surface density  
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3.1 Introduction 
 
The potential applications of gene transfer cover both basic and applied sciences 
and relate to functional genomics, gene therapy, and tissue engineering. In vivo 
gene delivery of naked DNA requires that the plasmid must overcome several intra 
and extracellular barriers that limit the efficiency of gene transfer. The 
complexation of plasmid DNA with viral or non viral vectors, supports the cellular 
internalization and transfection, but are not always assures the correct efficiency 
and duration of gene expression. Gene vectors, can facilitate intracellular 
trafficking, which includes endosomal escape, cytoplasmic transport, and nuclear 
entry, while also dissociating from the DNA to allow expression [1, 2]. Non-viral 
vectors, in particular, are safer and easier to prepare than viral vectors, but typically 
have lower efficiency and shorter duration of gene expression [3]. Relative to more 
traditional delivery methods, controlled delivery systems have the potential to 
overcome extracellular barriers, as well as enhance gene delivery [4]. These 
different approaches deliver vectors according to two main mechanisms: (i) 
polymeric release, in which the DNA is released from the polymer, or (ii) 
substrate-mediated delivery, in which DNA is retained at the surface. While 
forward transfection adds gene particles to previously seeded cells, substrate-
mediated delivery, also termed reverse transfection or solid-phase tranfection, 
immobilizes the DNA to a substrate that supports cell adhesion, placing the vector 
directly in the cellular microenvironment, which has been shown to enhance gene 
delivery [5]. Cells cultured on the substrate can internalize the DNA either directly 
from the surface, or after release from the surface. The retention or release of DNA 
from surface can be dictated by the strength and specificity of the molecular 
interactions between the vector and substrate. Specific interactions can be 
introduced through complementary functional groups on the vector and surface, 
such as antigen–antibody or biotin–avidin [6, 7]. Viral vectors have been designed 
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to specifically interact with biomaterials through the use of antibodies or covalent 
coupling to allow for site-specific gene delivery [8]. While poly(L-lysine) (PLL) 
and polyethylenimine (PEI), modified with biotin residues, have been complexed 
with DNA and bound to a neutravidin substrate [9]. The increase in the number of 
biotin groups per complex leads to increased binding, however, if the association of 
complexes with a substrate is too tight, endocytic uptake and transfection can suffer 
[10]. Alternatively, nonspecific mechanisms, including hydrophobic, electrostatic, 
and van der Waals interactions, can be used to bind viral and nonviral vectors to a 
substrate. These interactions, mainly, occur by adsorption of gene vectors to a 
polymeric systems, which have been shown to enhance the gene expression and 
cellular viability [4]. However nonspecific binding depends upon the molecular 
composition of the vector (e.g., lipid, polymer, protein) and the relative quantity of 
each (e.g., N/P) [4]. Although the immobilization of vectors provides many 
advantages concern to transfection efficiency, a correct balance between the 
binding of the vector to the substrate and the ability to release the vehicle for 
cellular uptake is required. The effective affinity of the vector for the substrate may 
also be influenced by environmental conditions (e.g., ionic strength, pH), binding-
induced conformational changes, or vector unpacking. Another limiting factor in 
nonviral gene delivery is the concentration of DNA at the cell surface [5]. 
Inefficient transfection of conventional bolus delivery systems is due to mass 
transport issues, indeed, the delivery process of the complexes to the cell surface is 
typically a diffusion-limited process, whereas reverse transfection can pre-load 
complexes at high levels onto the cell—substrate interface [10]. Increasing the 
amount of DNA immobilized at surface during reverse transfection increases 
expression levels [11]. On the other hand, aggregation effects due to high density 
of the complexes on substrate, may lead to weaker binding and consequent release 
from substrate. The chemistry of substrate also can affect the immobilization and 
expression of non viral vectors. Inclusion of PEG-like moieties, for instance, can 
increase the transfection efficiency of PEI polyplexes adsorbed to monolayers of 
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carboxylic endgroups [12]. Nevertheless, this increase cannot be attributed to an 
increase in complex binding or release, but the size and shape of adsorbed 
complexes is markedly affected.  
In this study PEG molecules were added to PEI/DNA complexes then adsorbed to a 
glass substrates. Morphology of PEGylated complexes modified substrate, cellular 
uptake profile and reverse transfection were characterized. In particular, substrate 
adsorption and transfection efficiency have been tested varying the amount of DNA 
complexes aspecifically immobilized at surface. To maximize cellular transfection, 
the density of the DNA complexes on substrate has to be sufficient to support gene 
expression yet not so excessive as to compromise cellular viability. Manipulating 
the concentration of the complexes on substrate has been possible to modulate the 
transfection efficiency, on the other hand the cellular uptake profile indicates that 
substrate release probably affect cellular transfection. 
 
 
3.2 Materials and Methods 
 
3.2.1 Materials 
 
The reporter plasmid encoding for enhanced green fluorescent protein (EGFP) 
driven by a cytomegalovirus (CMV) promoter was amplified in Escherichia coli, 
extracted and purified from bacteria culture using Qiagen plasmid kit (Santa Clara, 
CA). Tetramethylrhodamine-conjugated linear PEI (JetPEI-Rhod) was purchased 
from Polyplus-transfection SA (7mM ammine content, Illkirch, France). Linear 
PEI 25 kDa purchased from Polysciences (Warrington, PA) was conjugated to 
acryloyl-PEG-N-hydroxysuccinimmide (Ac-PEG-NHS, 3.4 kDa, Creative PEG 
Works, Winston-Salem, NC). Label IT® Tracker™ Intracellular Nucleic Acid 
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Localization Kit was purchased from Mirus Bio (Madison, WI, USA). LysoTracker 
Red DND-99 was purchased from Molecular Probes (Invitrogen, Oregon, USA). 
 
3.2.2 Cell culture 
Transfection studies were performed with NIH/3T3 mouse fibroblasts cultured in 
humidified 5 % CO2 atmosphere at 37 °C in Dulbecco’s modified Eagle’s medium 
with 4.5 g L
-1
 glucose (DMEM) (Gibco) supplemented with 10 % (v/v) bovine calf 
serum (BCS) (Gibco), 4 mM glutamine, 100 U mL
-1
 penicillin and 0.1 mg mL
-1
 
streptomycin in 100 mm diameter cell culture dish (Corning Incorporated, Corning, 
NY). The cells were routinely splitted using 0.25% trypsin (Trypsin-EDTA, 
Invitrogen) following standard protocols.  
 
3.2.3 Amplification and purification of plasmid DNA  
Plasmid DNA, p
CMV
EGFP, containing a reporter gene encoding for enhanced green 
fluorescent protein (EGFP) was used for transfection studies. The chemically 
competent DH5αTM bacterial strain (Escherichia coli species) was transformed with 
p
CMV
EGFP using heat shock method. The pDNA in the transformed culture was 
then expanded in E. coli in Lennox L Broth (LB Broth) supplemented with 100 mg 
L
-1
 ampicillin overnight at 37 °C in an incubator shaker at 300 rpm. Plasmid DNA 
was extracted and purified from bacterial culture using a Qiagen kit (Santa Clara, 
CA) according to the manufacturer’s specifications. The purity was confirmed by 
1% agarose gel electrophoresis follows by ethidium bromide staining and the 
concentration of pDNA solution was determined using a NanoDrop 2000 UV-Vis 
Spectrophotometer (Thermo Scientific, Wilmington, DE) by measuring the 
absorbance at 260nm.  
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3.2.4 Covalent labeling of plasmid DNA 
Plasmid DNA was covalently labeled with the cyanine dye Cy5 using Label IT
®
 
Tracker™ Intracellular Nucleic Acid Localization Kit (Mirus Bio, Madison, WI, 
USA). The labeling reaction was carried out at a ratio of 0.5 μl of Label IT® 
Tracker™ reagent to 1 μg of plasmid DNA for 1 h at 37 °C followed by an ethanol 
precipitation step to remove unbound Label IT reagent as recommended by the 
manufacturer’s instructors [13]. The labeled DNA was recovered by centrifugation 
at 13,000 rpm for 10 minutes. The pellet was washed with 70% ethanol and 
resuspended in H2O.  (3.6ppm) with  (The purity of labeled plasmid was confirmed 
by measuring the ratio of absorbance at 260 nm and 280nm  (A260nm/A280nm) at 
NanoDrop 2000 UV-Vis Spectrophotometer. 
 
3.2.5 Synthesis of PEG-PEI copolymer  
 
Linear Polyethylenimine (L-PEI) 25kDa (Polysciences, Warrington, PA) was 
conjugated to acryloyl-PEG-N-hydroxysuccinimmide (Ac-PEG-NHS, 3400 Da, 
Creative PEG Works, Wiston-Salem, NC, USA). Conjugation was carried out in 
solution by mixing a solution of PEI HCl 0.7 μmol dissolved in 1 mL of 20 mM 
HEPES, at pH 7.1, with 50 equiv of acryloyl-PEG-NHS dissolved in 0.7 mL of 
DMSO for 1h. After the incubation, Ac-PEG-PEI copolymer was dialyzed and 
lyophilized before use. The modification of PEI with PEG in the reaction product 
was determined by proton nuclear magnetic resonance spectrometry (
1
H-NMR) 
(400 MHz, Varian) using deuterated water (D2O) as solvent, the degree of PEG 
substitution was calculated by comparing the peaks of CH2CH2O (3.58 ppm) of 
PEG with CH2CH2NH (~ 2.5 – 3.1 ppm) of PEI [14, 15].  
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3.2.6 Complexes formation and characterization 
 
Plasmid DNA (p
CMV
EGFP) encoding for enhanced green fluorescent protein 
(EGFP), purified from bacteria culture using Qiagen exaction kit (Santa Clara, CA) 
was complexed with tetramethylrhodamine-conjugated linear PEI (JetPEI-fluoR 
7mM amine content, Polyplus-transfection, Illkirch, France) (maximum excitation 
at 555 nm; maximum emission at 580 nm) and PEG-PEI copolymer (0.01 mg mL
-1
 
in HEPES 100 mM) at final N/P ratio of 5. Both plasmid DNA (3μg) and PEI (6 μl 
jetPEI-R and 3 μl Ac-PEG-PEI) were diluted in 100 μl of 150 mM NaCl, rapidly 
mixed by pipetting up and down and adding PEI solution to DNA solution [16]. 
Polyplexes were allowed to stand for 20 min at RT before use.  
Measurements of size and ƺ-potential of DNA complexes were performed using a 
Zetasizer Nano ZS (Malvern Instruments, Worcestershire, UK). PEG-PEIpDNA 
complexes at N/P ratio of 5 were generated in deionized water to a DNA 
concentration of 27 μg mL-1 and subsequently diluted to a final concentration of 6 
μg mL-1, before the measurement. Zeta-potential was measured electrophoretically 
by the laser scattering technique using folded capillary cells. All measurements 
were done in triplicate, the mean value was recorded as the average of three 
different runs.  
 
3.2.7 Complexes adsorption on glass substrates 
 
After preparation PEGylated complexes were adsorbed by 2 h incubation on glass 
substrates. In order to evaluate the adsorption efficiency by fluorescence measures, 
plasmid DNA was labeled with Cy5 dye using Label IT® Kit (Mirus Bio) and 
DNA concentration of PEG-PEIpDNA complexes solutions was monitored before 
and after adsorption. Different polyplexes solutions at known DNA-Cy5 
concentration (6 – 12 – 19 – 24 μg mL-1) were adsorbed on Φ 12 mm glass slides 
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(Knittel glass, Germany) for 2 h at room temperature. After this incubation time, 
DNA-Cy5 concentration of the unbound complexes was detected via a standard 
curve, by measuring the fluorescence of DNA-Cy5 at 633 nm in a multi-well plate 
spectrofluorometer (Enspire 2300, Perkin Elmer, USA). The complexes adsorption 
efficiency was expressed as the difference between the complexes concentration 
initially incubated on the substrate and the concentration of unbound complexes 
after the incubation time, normalized on initial concentration, in percentage  
          
    
     
Where [Ci] and [Cf] are the initial and final concentrations of complexes solutions 
measured before and after adsorption process, respectively. The experiments were 
repeated in triplicate with different samples, for each DNA concentration tested. 
The density of DNA complexes immobilized to each sample was determined by 
normalizing the amount bound to area of substrate.  
 
3.2.8 Characterization of complexes modified substrates: AFM – SEM. 
 
Morphology and surface distribution of adsorbed complexes were scanned by 
atomic force and electron microscopy (AFM - SEM). Polyplexes was prepared and 
immobilized on glass substrates as described above. Two kind of samples were 
prepared with different amount of PEGylated complexes immobilized (1 – 2 μg 
DNA), after adsorption process, complexes modified substrates were rinsed with 
Milli-Q water to remove any traces of salt on surface, then the samples were 
allowed to dry in air. AFM experiments were carried out in “dry” conditions with a 
BioAFM NanoWizard II (JPK Instruments, Berlin, Germany) with a MLCT 
(Bruker, Billerica, MA, USA) silicon tip in contact mode at a scan rate of 1 Hz 
with a spring constant around 0.01 N m
-1
. Multiple measurements at different 
magnifications were taken in air, at room temperature, at 1240 x 1240 pixels 
resolution to obtain a good representation of the whole surface. Complexes 
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modified substrates were processed for visualization also by scanning electron 
microscopy (SEM). After complexes immobilization, samples were mounted on 
SEM stubs and coated using a SEM coating system (Cressingthon, 208 HR, UK) 
with 5 nm of platinum-palladium under an argon atmosphere, and analyzed by 
SEM (Zeiss, FEG Ultraplus, Germany) at an accelerating voltage of 8.7 kV, and at 
variable magnifications.  
 
3.2.9 Substrate-mediated transfection studies  
 
For substrate-mediated transfection studies, PEG-PEIpDNA complexes (1ug - 2ug 
DNA) generated at N/P ratio of 5 were adsorbed at the surface of glass substrates 
(Φ 12 mm Fluorodish, World Precision Instruments Ltd). Immediately following 
complexes immobilization, NIH3T3 cells were plated on complexes modified 
substrates at a density of 7000 cells cm
-2 
and incubated in culture medium at 37 °C 
and 5% CO2 until transfection was analyzed. The efficiency of gene transfer was 
monitored by expression of reporter transgene encoding for green fluorescent 
protein. Control studies were performed through bolus delivery of PEGylated 
complexes with NIH3T3 cells plated on Φ 12 mm fluorodish at density of 7000 
cells cm
-2
. Day after, the same the amount of DNA immobilized to the substrates 
was added free to the previously seeded cells for bolus delivery. Usually, the 
complexes deliver by bolus method were generated according to the same quantity 
of immobilized DNA on substrate for reverse transfection but in 10% of the 
volume [16]. Transfection was characterized through confocal laser scanning 
microscopy (CLSM). After scheduled incubation times, samples were fixed with 
4% paraformaldehyde (Sigma Aldrich, USA) for 20 min and stained with 40,6-
diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) (maximum excitation at 358 
nm; maximum emission at 461 nm) for nucleus detection. Transfection analyses 
were carried out using a laser scanning confocal microscope (Leica TCS SP5) 
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equipped with a 25 X objective. Image resolution was fixed to 1024 X 1024 pixels. 
Samples were detect by 2P (two-photon)-mode, 700nm laser line emitted by a 
Coherent Chameleon Ultra Laser and an argon laser, at wavelengths of 488 nm. 
The emitted fluorescence was detected between 420 and 480 nm and between 500 
and 530 nm, through different detector channels. The percentage of transfected 
cells was calculated as the ratio of the transfected cells, GFP-expressing cells, and 
total cell number, DAPI-stained cells, quantified by analysis of images using Image 
J software. All experimental conditions were performed in triplicate. 
 
3.2.10 Cellular internalization of DNA complexes 
To evaluated the amount of DNA complexes internalized by the cells after 
incubation on modified substrates, fluorescence of intracellular complexes was 
monitored by confocal laser scanning microscopy (CLSM). Samples were prepared 
as described above, immobilizing Cy5 labeled polyplexes at glass substrates and 
seeding NIH3T3 cells after adsorption process. Cells were harvested 24, 48, 72 h 
after exposure to complexes modified substrates and reseeded on cell culture dishes 
(Fluorodish), after 24 h culture samples were fixed using 4% paraformaldehyde 
(Sigma Aldrich) for 20 min at RT. To detect fluorescence intracellular, an inverted 
confocal microscope Leica TCS SP5 II equipped with a 63X/1.4 NA oil objective 
was used. Excitation of rhodamine-labeled PEI and Cy5-labeled pDNA was 
achieved using, respectively, the 543 nm and 633 nm excitation line, while the 
emitted fluorescence was detected, between 550 and 610 nm for rhodamine 
detection and between 650 and 750 nm for Cy5 detection. Image resolution was 
fixed to 1024 x 1024 pixels. The fluorescence of the PEGylated complexes 
internalized by the cells at different time points was quantified using Image J 
software. Data were reported as the percentage of cellular area (Acell)occupied by 
the internalized fluorescent complexes (Acomp) 
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    . 
 At least 15 cells were collected and analysed for each time point and each 
substrate. 
 
3.2.11 Lysosome co-localization 
 
To monitoring the amount of the internalized complexes co-localized with 
lysosomal compartments, cells on substrates and harvested from complexes 
modified substrates were incubated with 0.5 mL Lysotracker Red DND-99 
(Molecular Probes, Invitrogen) for 30 min at room temperature prior to confocal 
acquisition. Image were acquired with inverted SP5 Leica microscope equipped 
with a 63X oil immersion objective a resolution of 1024 x 1024 pixels. Sequential 
scanning was used to control for spectral overlap between fluorophores, with 8 line 
averaging to improve signal-to-noise ratios. Intracellular DNA-Cy5 complexes 
were visualized by excitation by a HeNe laser at 633 nm and fluorescence was 
observed at 650–750 nm, while lysosome were visualized by excitation by a HeNe 
laser at 543 nm and fluorescence was observed at 550–610 nm. Quantification of 
DNA complex localization within lysosomal compartments was estimated by 
calculation of Pearson’s coefficient using NIH ImageJ software JACoP plug-in 
[17]. 
 
3.2.12 Statistical analysis 
 
All quantitative date were reported as means ± standard deviation (SD). Statistical 
analyses were performed using a one-way analysis of variance (ANOVA). Results 
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were compared by analysis of variance (ANOVA) and a p-value < 0.05 was 
considered statistically significant. 
 
3.3 Results and Discussions 
 
3.3.1 PEG-PEI conjugate characterization  
PEG-PEI conjugation was characterized by 
1
H-NMR spectroscopy in D2O. 
1
H-
NMR spectra integration (Fig. 1) indicates that in the PEG-PEI copolymer there are 
about 1.5 PEG molecules for each PEI macromolecule [18] 
 
 
Figure 1 1HNMR spectrum of PEG-PEI copolymer in D2O. PEG substitution was determined by 
comparing the peaks of CH2CH2O (3.6 ppm) with CH2CH2N (2.7 – 2.9 ppm). 
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3.3.2 Size and Z-potential of PEGylated complexes 
Size and zeta potential of PEG-PEIpDNA complexes formed in water at N/P ratio 
of 5 were investigated by Zetasizer Nano-ZS. Results of DLS measurements 
indicate that PEGylated complexes were 133 ± 20 nm in size with a net charge of 
27 ± 7 mV (Figure 2). The polydispersity index (PDI) was approximately 0.1, thus 
indicating narrow size distribution, high uniformity in particle size distribution and 
overall general homogeneity of the sample. The size and surface charge of the 
complexes are both important parameters for their interaction and entry into cells 
[19, 20]. Adding PEG molecules on PEI/DNA complexes led a decrease of size and 
a change in shape of the adsorbed polyplexes which affect their transfection 
capability [12].  
 
 
Figure 2 Representative dynamic light scattering (DLS) spectra. a) Hydrodinamic size distribution b) 
zeta-potential of PEG-PEI-DNA complexes at N/P ratio of 5 measured in double distilled water. 
 
 
a)
b)
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3.3.3 Characterization of complexes modified substrates  
Morphology and distribution of PEG/PEIpDNA complexes adsorbed at glass 
substrates were assessed by atomic force and electron microscopy (AFM - SEM). 
SEM analysis of substrate surface have shown the circular morphology of the 
immobilized complexes and their surface distribution on glass substrates. In 
particular the figure 3, show an high density of complexes on substrate but indicate 
also a likely complexes aggregation, also as shown by the dimensions of 
fluorescent spots present on substrates in the cofocal images (Figure 4) 
 
 
Figure 3 SEM images of PEGylated complexes adsorbed to a glass substrate. 
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Figure 4 CLSM images of PEGylated complexes adsorbed to a glass substrate. (A) DNA-Cy5, (B) PEI-
Rhod, (C) merge of A and B images. 
 
 
Scanning of the substrates with different amounts of adsorbed complexes by atomic 
force microscopy (AFM), has displayed the different distribution of adsorbed 
complexes on the two kind of samples (1 – 2 μg DNA), but also the presence of 
larger aggregates on substrates with greater amount of immobilized complexes 
(Fig. 5).
 
The 3D projections of the AFM images highlight the feature heights of the 
complexes adsorbed on substrates, in particular, the adsorption of 1 μg or 2 μg 
DNA complexes produce surface protrusions with average heights of 110 nm and 
240 nm, respectively. The latter height values of adsorbed complexes are bigger 
than the characteristic diameter of PEGylated complexes (ca. 100-150 nm) [21, 22], 
the differences are most likely due to the formation of aggregates caused by the 
method of DNA complexes immobilization [23, 24].  
 
24 μm
A CB
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Figure 5 AFM images of complexes modified substrates. a) and c) 1 μg DNA complexes immobilized to 
glass substrate images at 50 μm and 100 μm magnification, respectively. b) and d) 2 μg DNA complexes 
adsorbed to substrate images at 50 and 100 μm  of magnification, respectively 
 
3.3.4 Complexes adsorption efficiency  
Complexes adsorption efficiency was calculated monitoring DNA complexes 
concentration, before and after immobilization process, by fluorescence measures 
of the DNA-Cy5 complexes present in solution. Results in table 1 indicate that 
varying the experimental DNA concentrations, the percentage of the PEGylated 
complexes immobilized at the surface of the glass substrates is on average 67 ± 3 
% concerning the amount of DNA complexes initially measured and incubated on 
substrates. Therefore, the surface density that complexes can cover changes with 
the DNA concentration at which the complexes are formed. Probably, high 
a) b)
d)
c)
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concentrations of complexes in solution involve their aggregation that prevents the 
interaction with substrate, resulting in lower adsorption efficiency.  
 
 
Table 1 Adsorption efficiency of PEGylated complexes to glass substrates. Ci initial concentration of 
complexes before adsorption process, μgi DNA quantities applied to the substrates before immobilization, 
Cf concentration of unbound complexes solution, % adsorption calculating as different percentage between 
the two concentration values 
 
 
3.3.5 Transfection efficiency  
Substrate-mediated transfection by PEGylated complexes adsorbed at glass 
substrates is influenced by DNA density immobilized on substrate. The percentage 
of transfected NIH3T3 cells by surface-adsorbed complexes increased with the 
amount of immobilized DNA-complexes ( 1 – 2 μg DNA) [Fig. 6 a]. Transfection 
efficiency was depends upon an appropriate balance between the time of exposure 
of the cells to complexes modified substrates and the amount of immobilized DNA. 
At 24 h transfection not occur for the samples with lower amount of DNA 
complexes adsorbed (1ug). Maximal number of transfected cells (26%) were 
observed with the highest quantity of surface-bound complexes (2 μg) in 48 h. For 
bolus delivery (Fig.6 b), addition of 0.7 μg of DNA complexes, which correspond 
to the effective amount of complexes adsorbed on substrate with lower DNA 
concentration, assure a transfection of 20% of the cell population in 48 h. This 
Ci
(ng/uL)
μgi
DNA
Cf
(ng/uL)
% Adsorption Surface 
Density
(μg/cm2)
6 0.5 0.75 87 0.43
12 1 3 70 0.7
19 1.5 6 68 1.02
24 2 8.5 65 1.22
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value of transfection efficiency is reached in 24 h with 1.4 μg of DNA complexes, 
which correspond to higher complexes functionalization of the substrate, added 
free in the control samples.  
 
 
Figure 6 Comparison of transfection efficiency by a) bolus and b) substrate-mediated delivery. blue bar for 
lower amount of complexes immobilized (1μg) or added free (0.7μg) in solution. red bar for higher amount 
of complexes immobilized (2μg) or free (1.4 μg) added free in solution 
 
3.3.6 Quantification and localization of internalized complexes  
To estimate the fraction of DNA complexes internalized by cells plated on 
modified substrates, NIH3T3 cells was detached from substrates at different time 
points, reseeded on inert dishes and fixed after 24 h. Fluorescence of intracellular 
complexes was monitored in time by CLSM analysis, and the amount of the DNA-
Cy5 complexes internalized, calculated by images elaboration, was expressed as 
the percentage area of the cells occupied by internalized complexes. Nearly all cells 
on surfaces with immobilized complexes had internalized DNA, at the same time, 
for substrate-mediated delivery, the majority of DNA complexes remained 
immobilized to the surface. Moreover, intracellular fluorescence of the internalized 
complexes was monitored at different time points (figure 7) . Results indicate that 
intracellular fluorescence increase until 48 h culture on complexes modified 
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substrates, no statistical variations were detect after this time point. This 
observation suggest a possible substrate release of complexes before cellular 
uptake. 
 
 
Figure 7 Quantification of internalized complexes by the cells seeded on modified substrates. Percentage 
cellular area occupied by internalized complexes during time 
 
 
We subsequently characterized the quantity of intracellular complexes co-localized 
with lysosomes. DNA complexes and lysosomes were imaged by confocal 
microscopy. The co-localization of DNA into lysosomal compartments was 
estimated by Pearson’s coefficient which describe how well are the DNA-Cy5 and 
lysosome-Rhod relate by a linear equation, if it will be equal to 1 all Cy5 voxels are 
exactly double in intensity than the Rhod ones. Taking in account this definition, 
we can conclude that for both samples and controls Pearson’s coefficient values 
indicate a lower percentage of internalized complexes co-localized with lysosomes 
(table 2) 
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Table 2 Pearson’s coefficient values 
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Chapter 4 
 
Specific adsorption of PEI/DNA complexes to 
fibronectin coated substrate through a peptide 
linker. 
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4.1 Introduction  
 
The opportunity to enhance gene transfer, characteristic of controlled delivery 
systems, is due to retention of elevated DNA concentration within the cellular 
microenvironment. The continued presence of the exogenous DNA during cell 
division, indeed, may also facilitate entry into the nucleus, during which the 
nuclear membrane is compromised [1]. Substrate-mediated delivery, in particular, 
involve the immobilization of gene vectors to a substrate that support cell adhesion, 
allowing for cellular internalization and reducing aggregation and mass transport 
limits [2]. Several strategies have been employed to associate DNA complexes 
with the substrate, including entrapment in gelatin followed by addition of the 
transfection reagent [3], poly-electrolyte layering of DNA [4], specific tethers 
through the biotin-avidin interaction [5-7] or non specific adsorption [8]. When 
delivered from a surface, the ability of nonviral particles to induce gene expression 
depends not only on their local concentration, but also on the tightness of their 
adsorption, on substrate surface chemistry, and on the presence of extracellular 
matrix (ECM) proteins [9]. DNA complexes can be adsorbed on uncoated substrate 
[10-14] or substrates coated with serum or extracellular matrix proteins to mediate 
cell adhesion and complex immobilization [15]. Gene transfer using collagen, for 
instance, is hypothesized to function by maintaining the DNA in situ, possibly due 
to limited transport through the collagen, until internalization by cells present 
locally [16, 17]. A similar strategy has been used by some viruses, which associate 
with extracellular matrix molecules (e.g., fibronectin) for enhanced uptake [18, 19]. 
More recently, synthetic systems that specifically bind viruses [20, 21] or nonviral 
DNA complexes [5] to a polymeric substrate are being developed. Manipulating 
the surface properties of a material through the adsorption of proteins, such as 
serum, mediates both DNA complex binding and cellular adhesion. Serum 
exposure on tissue-culture polystyrene substrates (TCPS) results in adsorption of 
fibronectin that supports cell adhesion [22], and immobilization of non-viral 
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vectors to the adsorbed proteins enhances gene transfer from the surface relative to 
no coating substrate [15]. Individual proteins or protein mixtures, such as serum, 
fibronectin, collagen, or laminin, are routinely deposited onto biomaterials to 
support cell adhesion [23-26]. In addition to mediating cell attachment and the 
immobilization of vectors, protein pre-adsorbed to surfaces, also used in reverse 
transfection, can improve transgene expression. The protein coating can potentially 
interface with cellular processes to direct internalization and intracellular 
trafficking [27-29]. Complexes delivered with protein may maintain conformations 
favorable for cellular uptake, or may be differentially trafficked. Several studies 
demonstrate that fibronectin deposited onto solid support dramatically increase the 
reverse transfection efficiency of polyplexes [8] and mediate the greatest levels of 
transgene expression compared to other extracellular matrix (ECM) proteins [15], 
which suggests an active role of fibronectin in the internalization and intracellular 
trafficking of gene complexes. Fibronectin is internalized by a caveolin-dependent 
pathway [29], and thus vectors associated with fibronectin may similarly be 
internalized via caveolae-mediated endocytosis [30]. Thus, the ECM protein targets 
the vector toward a specific internalization pathway that can influence the ultimate 
fate of the vector, as internalization via caveolae-mediated endocytosis may avoid 
the lysosome and subsequent degradation relative to internalization via clathrin 
mediated endocytosis [27, 28].  
Taking advantage of the adhesive properties and increased transfection efficiency 
induced by fibronectin coating, in this preliminary study we have specifically 
adsorbed DNA complexes to a solid substrate. In order to obtain a specific 
interaction between DNA complexes and fibronectin coated substrates, we have 
used a peptide linker with specific affinity for this protein. Several studies have 
shown fibronectin binding activity of synthetic peptides containing motifs, sites or 
some amino acids with particular affinity for a specific domain of the adhesion 
protein [31]. In particular, human plasma fibronectin was found to bind 
unexpectedly avidly to a 17 amino acid peptide (KRFKQDGGWSHWSPWSS) 
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from the second type I repeat of thrombospondin, an extracellular matrix 
glycoprotein. Roberts et al. have identified a hexapeptide (GGWSHW) within this 
sequence that accounts for this interaction. Furthermore, the peptide is a potent 
inhibitor of fibronectin binding to gelatin and of fibronectin-mediated cell adhesion 
to a gelatin or collagen matrix [31], which suggest the primarily interaction with 
the gelatin-binding domain of fibronectin. In this work, we have specifically 
immobilize PEI/DNA complexes to fibronectin coated substrates through the 
hexapetide GGWSHW, evaluating the effective affinity to fibronectin compared to 
a control peptide. Moreover, peptide has been conjugated with polyethylenimine 
(PEI), the product of this conjugation was adsorbed to fibronectin layer to allow the 
specific adsorption of PEI/DNA complexes. Finally, we have proposed a simple 
way to pattern the surface with fibronectin spots to create adhesive/transfective 
islands on solid substrate.  
 
 
4.2 Materials and Methods 
  
4.2.1 Materials 
 
Linear Polyethylenimine (L-PEI) with an average molecular weight of 25 kDa was 
purchased from Polysciences (Warrington, PA). Tetramethylrhodamine-conjugated 
linear PEI (JetPEI-fluoR) were purchased from Polyplus-transfection SA (7mM 
ammine content, Illkirch, France). The reporter plasmid encoding for enhanced 
green fluorescent protein (EGFP) driven by a cytomegalovirus (CMV) promoter 
was amplified in E. coli, extracted and purified from bacteria culture using Qiagen 
plasmid kit (Santa Clara, CA). Preliminary cellular adhesion studies were 
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performed with mouse embryo fibroblasts (NIH3T3), cultured at 37 °C and 5% 
CO2 in Dulbecco’s modified Eagle medium with 4,5 g L
-1
 glucose (DMEM, Gibco) 
supplemented with 10% Bovine Calf Serum (BCS, Gibco), 4 mM glutamine, 100 U 
mL
-1
 penicillin and 0.1 mg mL
-1
 streptomycin. For imaging, plasmid DNA 
(p
CMV
EGFP) was labeled with the cyanine dye Cy5 using Label IT® Tracker™ 
Intracellular Nucleic Acid Localization Kit purchased from Mirus Bio (Madison, 
WI, USA). Fibronectin from bovine plasma was purchased from Sigma Aldrich 
(St. Louis, MO, USA). Reagents for peptides synthesis (Fmoc-protected amino 
acids, resins, activation, and deprotection reagents) were obtained from Iris Biotech 
GmbH (Waldershofer Str. 49-51 95615 Marktredwitz, Deutschland) and InBios 
(Naples, Italy). Solvents for peptides synthesis and HPLC analyses were purchased 
from Sigma-Aldrich; reversed phase columns for peptide analysis and the LC–MS 
system were supplied respectively from Agilent Technologies and Waters (Milan, 
Italy). All chemicals were used as received.  
 
4.2.2 Peptides synthesis  
 
Solid phase peptide synthesis of fibronectin-adhesive peptide (6 aa) and control 
peptide (13 aa) was performed on a fully automated multichannel peptide 
synthesizer Biotage® Syro Wave™. The 6-mer and 13-mer peptides were 
synthesized in the amidate version, employing the solid phase method on a 50 μmol 
scale following standard Fmoc strategies. Rink-amide resin (substitution 0.45 
mmol/g) was used as solid support. Activation of amino acids was achieved using 
HBTU/HOBt/DIPEA (1:1:2). All couplings and deprotections were performed for 
15 and 10 min, respectivetly. Peptides were then removed from the resin, by 
treatment with a TFA/TIS/H2O (95:2.5:2.5, v/v/v) mixture for 90 min at room 
temperature; then, crude peptides were precipitated in cold ether, dissolved in a 
water/acetonitrile (1:1, v/v) mixture, and lyophilized. Product were purified by 
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preparative RP-HPLC on a Waters 2535 Quaternary Gradient Module, equipped 
with a 2489 UV/Visible detector and with an X-Bridge
TM
 BEH300 preparative 10 
× 100 mm C8, 5μm column, applying a linear gradient of 0.1% TFA CH3CN in 
0.1% TFA water from 5% to 70% over 30 min at a flow rate of 5 mL/min. Peptides 
purity (97%) and identity was confirmed by LC–MS analyses carried out on an 
Agilent 6530 Accurate-Mass Q-TOF LC/MS spectrometer with Zorbax RRHD 
Eclipse Plus C18 2.1 x 50 mm, 1.8 µm columns. Purified peptide were lyophilized 
and stored at −20 °C until use. 
 
4.2.3 Surface Plasmon Resonance  
 
The interactions between fibronectin with 6-mer peptide and 13-mer peptide were 
measured using the SPR technique with SensiQ Pioneer from AlfaTest (Rome, 
Italy). In order to measure the affinity of the peptides (analyte) with the protein 
(ligand), fibronectin was immobilized at a concentration of 10 µg/mL in a 10 mM 
acetate buffer pH 4.5 (flow 10 µL/min, injection time 20 min) on a COOH1 SensiQ 
sensor chip, using EDC/NHS chemistry (0.4 M EDC - 0.1 M NHS, flow 25µl/min, 
injection time 4 min), achieving a 1900 RU signal. Groups reactive residues were 
deactivated by treatment with ethanolamine hydrochloride 1 M, pH 8.5. The 
reference channel was prepared by activation with EDC/NHS and deactivation with 
ethanolamine. The binding assays were performed at 25 μL/min, with a contact 
time of 4 min, the 6-mer and 13-mer peptides were diluted in the buffer stroke, 
HBS (10 mM Hepes, 150 mM NaCl, 3 mM EDTA, pH 7.4).The injection of 
analytes (100 μL) was performed at the indicated concentrations. The association 
phase (kon) was followed for 180 s, whereas the dissociation phase (koff) was 
followed for 300 s. The complete dissociation of formed active complex was 
achieved by addition of 10 mM NaOH, for 60 s before each new cycle start. To 
89 
 
subtract the signal of the reference channel and evaluate the kinetic and 
thermodynamic parameters of the complex, the software QDAT analysis package 
(SensiQ Pioneer, AlfaTest) was used. For 6-mer peptide same experiment was 
conducted by One step injection as well. In this case an analyte concentration of 
826 µM was used with a flow rate of 25 µL min
-1
 and a 600 sec of dissociation 
time. In this experiment the volume of sample was configured as a percentage of 
the dispersion loop volume, so in order to have a longer plateau at full 
concentration the largest percentage (100%) was used. As to bulk standard cycles, a 
3% of sucrose was used. For all experiments, kinetic parameters for both peptides 
(hexa- and control peptide) were estimated assuming a 1:1 binding model and 
using QDAT software (SensiQ Technologies). 
 
 
4.2.4 Specific adsorption of hexapeptide to fibronectin  
In order to demonstrate the specific adsorption of 6-mer peptide to a fibronectin 
layer, a fixed peptide concentration solution (70 μM) was analyzed before and after 
adsorption process by RP-HPLC, following tryptophan signal at 280nm. The 
indicated amounts of protein were diluted in phosphate buffered saline (PBS), 
added to glass slides of 12 mm diameter (Knittel glass, Germany) and incubated for 
2 hours. In particular, the adsorption of the same concentration of the 6-mer peptide 
(70 μM) was tested on three different fibronectin coating concentrations (10 – 30 – 
50 μg mL-1) and on uncoated glass substrate, as control. 
 
4.2.5 PEI-peptide conjugation 
In order to synthesize a peptide–polymer hybrid a solid phase chemical synthesis 
method was used. Immediately after peptide synthesis, the amine group of the last 
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glycine residue of the hexapeptide (GGWSHW) was activated for 1 h by 
disuccimidyl carbonate (DSC, Sigma Aldrich) on the resin support in a synthesis 
column, while the side chains of other peptide residues were still protected. After 
washing the column to remove excess DSC, the activated peptide was mixed with a 
small excess of PEI 25 kDa (Polyscience, SA) and the two compounds were 
allowed to react for overnight. The column was washed again to remove free PEI. 
The peptides were then deprotected, cleaved from the resin, and precipitated with 
ether. The crude complex was purified by RP-HPLC as previously described for 
peptide purification. Since PEI is not detected by ESI-QTOF, HPLC most relevant 
peaks were tested by proton nuclear magnetic resonance spectrometry
 
(
1
H-NMR). 
HPLC fractions were lyophilized and resuspended in H2O/D2O mixture for NMR 
analysis. 
1
H-NMR spectra were recorded on an Agilent 600 MHz spectrometer 
equipped with a DD2 console and a OneNMRprobe. The formed complex (Figure 
1)  was tested by RP-HPLC, monitoring peptide and PEI UV signal, using a linear 
gradient as previously described. The same procedures were performed for the 
conjugation of PEI to peptide control. 
 
 
 
Figure 1 Chemical structure of PEI 25 kDa conjugated to 6-mer peptide through the formation of an 
amide bond  
 
PEI 25 kDa Hexapeptide (GGWSHW)
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4.2.6 Substrate coating, PEI/DNA complexes formation and immobilization  
 
To preliminary test the co-immobilization of PEI-peptide and PEI/DNA 
complexes, a fibronectin layer was immobilized to glass coverslips (Φ 12 mm) by 2 
h incubation. After protein adsorption, substrates were washed with 1 X PBS and 
further incubated for 2 h with PEI-peptide conjugate dissolved in water at final 
concentration of 16 μM. PEI/DNA complexes were formed in 150 mM NaCl at an 
N/P ratio of 5, adding PEI solution dropwise to a solution containing DNA, 
vortexed for 10 s and incubated for 15 min at room temperature [32]. Complexes, 1 
μg DNA for substrate, were immobilized by incubation on fibronectin coated glass 
slides modified with PEI-hexapeptide for 2 h and were then washed twice with 1 X 
PBS. In order to imaged cell on this substrates, 5000 cells were seeded on 
specifically adsorbed complexes to fibronectin coated glass substrates. After 24 h, 
samples were fixed with 4 % paraformaldehyde (Sigma Aldrich), and actin staining 
was performed by incubating samples with TRITC-phalloidin (Sigma) in PBS for 
30 min at room temperature.  
 
 
4.2.7 Indirect immunofluorescence 
 
Indirect immunofluorescence was performed on samples after cells plated on 
PEI/DNA complexes adsorbed specifically to through linker hexapeptide to detect 
fibronectin coat. The samples, prepared as described above, were incubated with 
0.5 % (w/v) bovine serum albumin (BSA, Sigma Aldrich) dissolved in phosphate 
buffer saline solution (PBS) for 30 min at RT to prevent non specific staining. 
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Then, they were stained by incubation for 1 h at RT with a specific mouse 
monoclonal antibody (Sigma Aldrich) with affinity for the fibronectin cell binding 
domain diluted at 1:200 in PBS 0.5 % BSA. Bound antibodies were revealed by 
incubation for 1 h with 1:500 Alexa-fluor 488 anti-mouse secondary antibodies 
(Invitrogen, Life Technologies) diluted in PBS 0.5 % BSA. After rinsing in 1 X 
PBS, the samples were investigated with a Leica TCS SP5 II confocal laser 
microscope, equipped with an argon laser, at a wavelength of 488 nm, and a HeNe 
laser, at a wavelength of 543 nm and 633 nm. Images were acquired with 25x 
objective at resolution of 1024 x 1024 pixel. 
 
4.2.8 Generation of adhesive/transfective islands  
In order to built adhesive/transfective islands, 500 μm diameter spots of protein 
was obtained through the stamp of fibronectin on glass slides. For the stamp 
fabrication, the negative of micropillars array (stamp) was tooled from a PMMA 
substrate by using the micro-milling technique (Mini-Mill/GX, Minitech 
Machinery Corporation), to form a cylindrical cavity with a diameter of 500 μm 
and a depth of 200 μm. Then, a flexible layer with micropillars was obtained by 
pouring poly(dimethylsiloxane) (PDMS, Dow Corning 184 Sylgard), mixed in ratio 
10:1 with curing agent on the above described master and under vacuum until 
complete disappearance of the air bubbles. Finally, PDMS was cured at 80 °C for 
30 min and peeled off from PMMA master. The quality of the stamps obtained was 
investigated under a microscope. The desired stamps were then placed in an 
ultrasonic bath containing 70% ethanol for 5 min for sterilization and then dried 
under a flow of nitrogen gas [33]. After drying, a plasma cleaner (Femto, Diener, 
Bӧblingen, Germany) was used to remove the surface layer of organic compounds 
and oxidize the surface of PDMS stamps. To print of the protein of glass surface, 
stamps were inked with 20 μl of fibronectin 50 μg ml-1, the solution was left at 
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room temperature for 10 min in order to bind protein to the surface of the stamp. 
Once the incubation was complete, the stamps were then immediately placed into 
contact with a glass coverslips for 10 s, then peeled off and the printed coverslip 
was dried for 2 h [34].  
 
 
 
Figure 2 Scheme of protein patterning strategy use to generate adhesion island cultures. The stamp was 
inked with fibronectin solution, before printing the protein onto a glass slide. 
 
 
4.3 Results and Discussions 
 
4.3.1 Peptide synthesis 
 
6-mer and 13-mer peptides used to test fibronectin affinity were chemically 
synthesized with good yields by SPPS, using Fmoc methodologies as C-terminal 
amidated derivatives and purified by RP-HPLC. Their identity and purity (averaged 
purity > 97%) were assessed by LC–MS. The table 1 show the amino acid 
sequences of two peptides, with expected and experimental molecular weight. The 
figures 3a and 3b display the LC–MS spectra of crude and pure hexapeptide, 
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respectively. Whereas, figures 4a and 4b show LC–MS spectra of crude and pure 
control peptide, respectively. 
 
 
Table 1 Amino acid composition of fibronectin binding peptides with theoretical (th) and experimental 
(exp) molecular weights (MW)  
 
 
 
Figure 3 LC-MS analysis of 6-mer peptide. (A) LC-MS spectrum of crude peptide, (B) LC-MS spectrum 
of pure peptide 
 
Amino Acid Sequence Theoretical MW (g mol-1) Experimental MW (g mol-1)
6-mer peptide GGWSHW 727.78 728.32
13-mer peptide WKVDFEEDTLPKD 1620.78 1621.79
A B
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Figure 4 LC-MS analysis of 13-mer peptide. (A) LC-MS spectrum of crude peptide and (B) LC-MS 
spectrum of pure peptide 
 
 
4.3.2. Hexapeptide-fibronectin binding affinity_SPR 
 
Several synthetic peptides from fibronectin have been shown to inhibit interactions 
of fibronectin with cell surface integrin receptors [35] Previous investigations have 
shown that both hexapeptide (GGWSHW) and 13-mer peptide binds specifically 
fibronectin, in particular, the latter is part of a 38 amino acid long motif contained 
into membrane receptors of Staphylococcus aureus [36]. 6-mer and 13-mer peptide 
ability to bind fibronectin was evaluated by surface plasmon resonance (SPR) 
experiments. Fibronectin (ligand) was immobilized on COOH1 chip, achieving 
1900 RU immobilization level, according to reported conditions (see Materials and 
Method section for details). Direct binding between fibronectin and 6-mer and 13-
mer peptides were performed by injecting peptides solutions at increasing 
concentrations from 3µM to 826µM for shorter peptide and from 4.7 µM to 1.2 
mM for the longer one. Only for 6-mer sequence a clear association to fibronectin 
A B
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protein was shown by SPR technique as demonstrated by the dose-response overlay 
of sensorgrams reported in figure 5a.  
 
 
Figure 10 Binding of 6-mer peptide and fibronectin protein. a) Conventional SPR experiment, analyte 
concentration ranging from 3 μM to 826 μM. b) One Step injection, analyte concentration of 826 μM. 
 
Employing a 1:1 interaction model, a low micromolar dissociation value for 6-mer 
peptide/fibronectin complex was shown. A good fitting was obtained using a 1:2 
interaction model, suggesting the presence on fibronectin sequence of two different 
a)
b)
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binding sites for 6-mer peptides. First site shows a higher and more specific affinity 
than the second one. (Table 2). 
 
 
Table 2 Kynetic parameters for both peptides (hexa- and control peptide) for Conventional and One 
Step experiments 
 
Using the same condition a One Step experiment was conducted as well. This kind 
of experiment is based on Taylor dispersion theory [37], so a unique concentration 
of peptide (826µM) was dispersed into running buffer directly in the flow cell in 
order to have a final sigmoidal profile.(Figure 5b). Employing a 1:1 interaction 
model, a low micromolar dissociation value for 6-mer peptide/fibronectin complex 
was shown, that was in according to conventional SPR experiment. Even with One 
Step injection, the presence of two binding sites (the first one  with a higher affinity 
and the second with a weak affinity) was confirmed. While for 13-mer peptide 
6-mer peptide
Conventional method
KD Rmax
1 site 490 ± 0.1 μM 256 ± 1
2 site 20 ± 0.2 μM 10 ± 2
One step
KD Rmax
1 site 3.96 ± 0.09 mM 700 ± 0.1
2 site 32.6 ± 0.05 μM 36.8 ± 0.3
13-mer peptide
Conventional method
KD Rmax
1 site 900 ± 0.2 mM 69.7 ± 0.9
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there is no a clear association to the protein, the figure 6 shows a typical aspecific 
sensorgram with a low millimolar dissociation value. This result probably suggest 
the importance of whole sequence, 38-mer peptide, for fibronectin binding. 
 
 
 
Figure 6 Binding of 13-mer peptide and fibronectin protein 
 
4.3.3 Binding specificity 
 
Adsorption specificity of peptide GGWSHW toward fibronectin was evaluated by 
RP-HPLC technique, measuring peptide concentration of unbound fraction after 
binding process. Three distintic layers of fibronectin at different concentrations (10 
– 30 – 50 μg ml-1) were used to test the specific adsorption of the 6-mer peptide at 
initial concentration of 70 μM. Figure 7 show three release profiles of the unbound 
peptide at different fibronectin layers. Higher peak reveal higher release from 
substrate with lower fibronectin concentration coat. While, lower peak show higher 
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adsorption to fibronectin coated substrate with higher concentration, therefore 
lower peptide concentration released.  
 
 
 
Figure 7 Reverse-phase-HPLC of 6-mer peptide specific binding on fibronectin coated glass. The 
chromatograms performed at 280 nm shows un bound peptide fractions at three different fibronectin 
layers. Black peak shows the 6-mer peptide release after incubation on 10 μg/mL fibronectin layer. 
unlike blue and green peaks show unbound peptide after binding with 30 and 50 μg/mL protein layers, 
respectively. 
 
4.3.4 PEI-peptide conjugate characterization 
The conjugation of the hexapeptide (GGWSHW) to linear PEI 25 kDa was 
confirmed by 
1
H-NMR spectroscopy. Wang et al. reported that PEI metylen peak 
shifts from 2.5 to 3 ppm when it forms an amidic bond with the activated amino 
terminal group of the peptide. NMR spectrum of peptide-PEI is shown in fig. 8. A 
very intense peak is found at 3 ppm confirming the covalent binding of PEI to the 
peptide. Signals at around 10 ppm are typical of Trp indolic protons where signals 
in the region from 8 to6 ppm become to peptide backbond amide and side chains 
aromatic protons.  
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Figure 8 NMR spectra of PEI-6-mer and PEI-peptide complex. The shift of PEI peak (B) from 2.7 to 3.2 
ppm confirms the correct covalent bond between peptides and polymer, the signals at 10 ppm and at 8-6 
ppm typical of Trp residues and peptide backbone amide and side chains are visible in the spectrum (A). 
A
B
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The correct PEI-Peptide conjugation was confirmed by RP-HPLC, as well. In the 
figure 9 PEI-peptide crude complex chromatogram was reported. The presence of a 
non sharp peak at 230 nm that covers tryptophan peak at 280nm indicates the 
correct complex formation for both peptides. 
 
Figure 9 RP-HPLC analysis of PEI-peptide complex. a) 6-mer complex at 280 nm in blue and at 220 nm 
in black. The presence of a non sharpe peak at 220 nm confirms the correct formation of the complex 
that is not visible at 280 nm.  
 
4.3.5 Imaging of PEI/DNA complexes specifically adsorbed to fibronectin 
coated substrates and adhesive/transfective islands 
 
Results of immunofluorescence on samples with cells seeded on PEI/DNA 
complexes specifically adsorbed to fibronectin coated substrates and fibronectin 
stamps to glass slides such as adhesive islands were shown in the figure 10 and 11. 
Figures show blue spots of PEI/DNA complexes adsorbed to green layer/spots of 
fibronectin and cell seeded on this system with red cytoskeleton.  
 
102 
 
 
Figure 10 CLSM image of cell on complexes specifically adsorbed to fibronectin coated substrate 
through linker 6-mer peptide  
 
 
Figure 11 CLSM image of array of printed fibronectin spots.  3×3 array of 500 um diameter islands of 
fluorescently labeled IgG generated by contact printing 
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